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Compulsive washing and contamination fear are among the most common symptoms of 
obsessive-compulsive disorder (OCD).  Exposure and response prevention (ERP) is an effective 
treatment for OCD, but a substantial proportion of clients/patients refuse this treatment entirely 
or drop out prematurely.  A proposed solution involves the judicious use of safety behaviour to 
enhance the acceptability of ERP.  However, to this author’s knowledge, there are currently no 
published guidelines for the judicious use of safety behaviour in exposure, and questions remain 
about how best to incorporate safety behaviour into existing treatments.  For instance, which 
kinds of safety behaviour may be beneficial in treatment, and which may be harmful?  Who 
decides when to eliminate the safety behaviour during treatment, the client/patient or the 
therapist?  The present studies made a first attempt at addressing these questions.  In the first 
study, a clinical sample of individuals with contamination-related OCD (N = 60) was randomized 
to receive an exposure session with no safety aid (ERP), a routinely-used safety aid (RU), or a 
never-used safety aid (NU).  Significant reductions in contamination fear severity were observed 
in all conditions.  However, participants in the NU condition demonstrated the lowest self-
reported contamination fear severity at post-treatment.  Further, the NU condition received the 
highest acceptability and anticipated adherence ratings.  In the second study, a subclinical sample 
of undergraduate students (N = 100) was assigned to complete an exposure session for 
contamination fear under one of three fading conditions: participant-initiated, experimenter-
initiated (based on time), or experimenter-initiated (based on participant-reported distress levels).  
Compared to the experimenter initiated time-based condition, the participant-initiated condition 
demonstrated significantly greater reductions in obsessive beliefs and peak fear, as well as 
marginally higher treatment expectancy ratings.  There were no differences in outcome or 
acceptability between the participant-initiated and experimenter initiated distress-based 
iv 
 
conditions.  The results of these studies are discussed in terms of the cognitive-behavioural 
theory and treatment of anxiety and related disorders, and of the potential benefits of judiciously 
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Obsessive-compulsive disorder, contamination fear, and evidence-based treatment  
 Obsessive-compulsive disorder (OCD) is characterized by obsessions, or unwanted, 
intrusive, and distressing thoughts, images, or impulses, and/or compulsions, which are repetitive 
behaviours aimed at decreasing anxiety and/or preventing feared outcomes (APA, 2013).  OCD 
affects 1-2% of the population (Kessler et al., 2005), and individuals with OCD experience 
significant functional impairment and poor quality of life as compared to healthy individuals 
(Huppert, Simpson, Nissenson, Liebowitz, & Foa, 2009; Norberg, Calamari, Cohen, & Riemann, 
2008).  OCD is a heterogeneous disorder, encompassing a wide variety of obsessions and 
compulsions (McKay et al., 2004; Rachman & Hodgson, 1980; Radomsky & Taylor, 2005).  
One of the most common symptoms of OCD is contamination fear, which is often accompanied 
by compulsive washing and cleaning rituals (Rachman, 2004; Rasmussen & Eisen, 1992; 
Rachman & Hodgson, 1980).  For instance, Ball, Baer, and Otto (1996) reported that 75% of 
participants in OCD treatment studies endorsed washing and/or checking rituals.  Furthermore, 
there is some evidence to suggest that individuals with compulsive washing rituals respond less 
well to cognitive-behavioural therapy (CBT) than individuals with other kinds of compulsions 
(Coelho & Whittal, 2001; McLean et al., 2001).  This may be because contamination fears are 
persistent and unrelenting, and generally do not decay over time (Rachman, 2004; Tolin, 
Worhunsky, & Maltby, 2004).  The complex and multi-faceted nature of contamination fear may 
also make this symptom more difficult to target in treatment.  For example, a growing body of 
literature suggests that mental contamination, defined as feelings of contamination that arise 
without direct contact with a contaminant (Rachman, 2004), is commonly endorsed by 
individuals with contamination-related OCD (Coughtrey, Shafran, Lee, & Rachman, 2012; 
Radomsky, Rachman, Shafran, Coughtrey, & Barber, 2014).  Disgust, which is a basic emotion 
that is characterized by a revulsion response and subsequent avoidance of perceived 
contaminants (Rozin & Fallon, 1987), has also been implicated in the onset and maintenance of 
contamination fear.  For instance, Cisler, Brady, Olatunji, and Lohr (2010) found that disgust 
propensity interacted with certain domains of obsessive beliefs (e.g., the tendency to 
overestimate the likelihood of threat) to predict the severity of contamination fear, even after 




than anxiety during exposure to threatening stimuli (e.g., Olatunji, Smits, Connolly, Willems, & 
Lohr, 2007), which may lead to poorer treatment response among anxious individuals with 
elevated disgust propensity (Olatunji, Wolitzky-Taylor, Willems, Lohr, & Armstrong, 2009).  
For all of these reasons, it is important to develop effective and acceptable treatments for 
contamination-related OCD. 
 Fortunately, there are several evidence-based treatments for OCD, including cognitive 
therapy (e.g., Freeston, Léger, & Ladouceur, 2001; McLean et al., 2001; Wilhem et al., 2005, 
2009), pharmacotherapy consisting of selective serotonin reuptake inhibitors (e.g., Franklin & 
Foa, 2011; Greist et al., 1995; Zohar & Judge, 1996), and exposure and response prevention 
(ERP; e.g., Deacon & Abramowitz, 2004; Foa et al., 2005; Franklin & Foa, 2008, 2011; for a 
review, see McKay et al., 2015).  ERP is arguably the most widely studied psychological 
treatment for OCD, perhaps due to its longstanding history.  In 1966, Victor Meyer published the 
first case report of ERP in the treatment of OCD.  As described by Meyer, the treatment 
consisted of preventing patients with OCD from engaging in compulsive behaviour, which 
eventually resulted in a “modification of expectations” regarding the necessity of these rituals.  
This “modification of expectations” method of treatment laid the foundation for what is now 
referred to as ERP, involving the gradual and systematic exposure to feared stimuli while 
preventing compulsive behaviour.  Since 1966, the findings from numerous clinical trials support 
the efficacy of ERP (e.g., Abramowitz, Foa, & Franklin, 2003; Foa et al., 2005, 2013), and as 
such it is considered by some to be the “gold standard” treatment for OCD (March, Frances, 
Carpenter, & Kahn, 1997).   
 Despite the efficacy of ERP, 20-40% of treatment-seeking individuals decline to 
participate in ERP or drop out prematurely (Foa et al., 2005; Stanley & Turner, 1995; Whittal, 
Thordarson, & McLean, 2005).  This means that a significant number of OCD sufferers are not 
receiving effective treatment for their OCD.  Reasons for these problematic dropout rates are 
largely unknown, as there is a paucity of literature investigating predictors of refusal and dropout 
in OCD.  Some research indicates that individuals with more severe OCD symptoms may be 
more likely to drop out of treatment (Aderka et al., 2011), whereas other research has not found 
differences in symptom severity between those who drop out of and those who complete OCD 
treatment (Foa et al., 2005; Rector, Cassin, & Richter, 2009; Whittal et al., 2005).  Similarly, 




(Aderka et al., 2011; Rector et al., 2009; Whittal et al., 2005), although other investigators have 
failed to replicate this effect (Mancebo, Eisen, Sibrava, Dyck, & Rasmussen, 2011).  Given these 
mixed findings, it may be more informative to investigate client/patient perceptions of exposure 
therapy as a potential predictor of dropout, rather than baseline symptom severity.  Indeed, in a 
longitudinal study of CBT utilization, Mancebo et al. (2011) found that fear of CBT was a 
commonly endorsed reason for refusal and/or dropout in individuals with OCD, perhaps due to 
the fact that exposure to feared stimuli often causes (albeit temporary) severe anxiety and 
distress.  Consistent with these findings, Richard and Gloster (2007) found that vignette-based 
descriptions of exposure therapy, including ERP for OCD, were rated as unacceptable and/or 
unlikely to be helpful in a sample of individuals seeking treatment at a university-based clinic.  
In another study conducted at a university-based CBT clinic, Bados, Balaguer, and Saldaña 
(2007) reported that dissatisfaction with the treatment or therapist was a commonly reported 
reason for premature termination.  As such, perceptions of treatment acceptability are likely to 
play a role in determining who drops out of ERP and other exposure-based treatments for anxiety 
disorders.   
Furthermore, there is growing evidence to suggest that practitioners as well as clients 
may hold negative beliefs about exposure therapy for anxiety.  For instance, Deacon, Lickel, 
Farrell, Kemp, and Hipol (2013) surveyed a sample of practitioners who were recruited from the 
website of the Anxiety Disorders Association of America (ADAA).  In this study, respondents 
were asked to imagine a clinician delivering interoceptive exposure to a client with panic 
disorder, and then to rate the likelihood of certain negative outcomes (e.g., “the client would pass 
out/lose consciousness”).  Results showed that the majority of participants rated all negative 
outcomes as at least somewhat likely to occur, with premature termination of the exposure 
session being the outcome that was rated as most likely to occur.  It should be noted that only 
practitioners who reported that they were currently using exposure in the treatment of their 
anxious clients were included in the study, suggesting that even clinicians who are trained in 
exposure may have negative perceptions of the treatment.  Given these findings, perhaps it is 
unsurprising that not all clinicians actually use exposure therapy in their practice.  In a survey of 
licensed psychologists from three states, Becker, Zayfert, and Anderson (2004) found that only 




anxious clients.  Taken together, these results indicate that exposure is effective but generally 
underutilized, both by clients/patients and by trained clinicians.  
Consistent with these findings, Rachman, Radomsky, and Shafran (2008) theorized that 
exposure therapy can be unnecessarily demanding and threatening, thus increasing the likelihood 
of dropout from this treatment.  To address this problem, the authors suggested that the judicious 
use of safety behaviour, defined as the careful and strategic incorporation of safety behaviour 
into the early and/or most challenging stages of treatment, may enhance the acceptability of 
exposure.  Consistent with this theory, some research suggests that safety behaviour enhances the 
acceptability of CBT (Levy & Radomsky, 2014; Levy, Senn, & Radomsky, 2014; Milosevic & 
Radomsky, 2013a), whereas at least one other study did not find differences in perceptions of 
acceptability between traditional exposure and exposure with safety behaviour (ESB; Deacon, 
Sy, Lickel, & Nelson, 2010).  Given the mixed findings, more research is needed to clarify the 
impact of safety behaviour on treatment acceptability, dropout, and outcome in CBT.   
Safety behaviour  
Safety behaviour has been defined as overt/observable (e.g., cleaning, washing) or 
covert/subtle (e.g., distraction, avoiding eye contact with feared stimuli) avoidance strategies that 
are carried out in feared situations to decrease anxiety and/or minimize the likelihood of 
perceived threat (Salkovskis, 1991; Salkovskis, Clark, & Gelder, 1996; Thwaites & Freeston, 
2005).  According to traditional cognitive-behavioural models of anxiety and related disorders, 
safety behaviour is proposed to prevent disconfirmatory experiences via a misattribution of 
safety in threatening situations.  Due to this misattribution, anxious individuals are thought to fail 
to disconfirm the likelihood and/or relative dangerousness of their feared outcome(s) 
(Salkovskis, 1991; Salkovskis et al., 1996; Thwaites & Freeston, 2005).  From this theory, it 
follows that safety behaviour may interfere with the efficacy of exposure-based treatments, as 
clients/patients who employ safety behaviour during treatment may falsely attribute the success 
of the exposure and/or the non-occurrence of feared outcomes to the presence of the safety 
behaviour.  Consistent with this theory, numerous studies have shown that safety behaviour 
interferes with the efficacy of exposure, such that participants who used safety behaviour during 
exposure demonstrated poorer outcomes in terms of anxiety reduction and cognitive change than 
participants who refrained from using safety behaviour (Kim, 2005; McManus, Sacadura, & 




& Alden, 2010).  As demonstrated by Powers, Smits, and Telch (2004), even the availability of 
safety behaviour can undermine treatment success.  In this study, participants who were given 
access to safety behaviour and told to use it “only if they must” demonstrated poorer outcomes as 
compared to participants who did not use safety behaviour during exposure.  Based on these 
findings, many cognitive-behavioural treatment manuals and books advise against the use of 
safety behaviour during exposure, or recommend that it be eliminated as soon as possible (e.g., 
Abramowitz, Deacon, & Whiteside, 2011; Antony & Swinson, 2000; Foa, Yadin, & Lichner, 
2012).  In fact, a novel transdiagnostic treatment that emphasizes safety behaviour elimination 
has been developed, and it showed initial promise as compared to wait-list control (Schmidt et 
al., 2012).  Taken together, these findings support the notion that safety behaviour is counter-
therapeutic, and thus should be discouraged in treatment.  
In contrast, numerous other studies have failed to find a deleterious effect of safety 
behaviour on treatment outcome in exposure therapy (Hood, Antony, Koerner, & Monson, 2010; 
van den Hout, Engelhard, Toffolo, & van Uijen, 2011; Milosevic & Radomsky, 2008, 2013b; 
Rachman, Shafran, Radomsky, & Zysk, 2011; Sy, Dixon, Lickel, Nelson, & Deacon, 2011).  In 
these investigations, participants using safety behaviour during exposure demonstrated 
comparable improvement in terms of fear reduction and cognitive change as participants who did 
not use safety behaviour.  In fact, some studies have even found more favourable outcomes 
among participants receiving ESB than those receiving traditional exposure.  For instance, 
Milosevic and Radomsky (2013b) found that spider-fearful participants who used safety gear 
(e.g., gloves, face masks) during a behavioural experiment with a spider demonstrated greater 
change in targeted threat beliefs about spiders than participants who did not use safety gear.  
Importantly, these studies do not support the theory that safety behaviour is counter-therapeutic, 
and instead suggest that safety behaviour may actually facilitate disconfirmation in some cases.  
Consistent with these contradictory findings, some theoretical work has questioned the necessity 
of eliminating safety behaviour in treatment (Parrish, Radomsky, & Dugas, 2008; Rachman et 
al., 2008), while others have called for more accurate categorization of safety behaviour as 
adaptive (e.g., used to facilitate approach behaviour and/or the acquisition of disconfirmatory 
information) versus maladaptive (e.g., used to prevent unlikely or imagined feared catastrophes) 
coping strategies (Thwaites & Freeston, 2005).  Proper categorization of safety behaviour is 




safety behaviour may be detrimental versus beneficial to treatment outcome.  Nevertheless, it is 
clear that the unqualified rejection of safety behaviour is unnecessary and unfounded (Rachman 
et al., 2008). 
In addition to Salkovskis’ (1991) initial formulation, several other theories have been 
proposed to explain the effect of safety behaviour in CBT, either in terms of being counter-
therapeutic or potentially facilitative.  Traditional behavioural theory suggests that safety 
behaviour interferes with initial fear activation (IFA), such that individuals who employ safety 
behaviour during exposure fail to achieve an adequate level of anxious arousal for corrective 
learning to occur.  According to emotional processing theory, greater IFA corresponds to better 
outcomes in exposure-based treatments.  As such, any activities which reduce IFA (e.g., 
employing safety behaviour to reduce anxiety) will interfere with the success of treatment (Foa 
& Kozak, 1986).  In a more cognitively-based theory, Sloan and Telch (2002) proposed that 
safety behaviour prevents the processing of disconfirmatory experiences, as individuals who 
employ safety behaviour have less attentional resources available to process threat-relevant 
information.  In a neurobehavioural approach, inhibitory learning theory posits that safety 
behaviour has the potential to interfere with the development of inhibitory (non-threat) 
associations during exposure (Craske, Treanor, Conway, Zbozinek, & Vervliet, 2014).  However, 
these authors noted that the degree to which safety behaviour interferes with inhibitory learning 
depends on the strength of the safety behaviour in reducing anxiety, as well as the strength of the 
feared stimulus in provoking anxiety.  As such, the use of safety behaviour may not necessarily 
be counter-therapeutic so long as the exposure is potent enough to elicit the fear response and 
thus, make it possible to acquire accurate threat-relevant information.   
To explain the potentially facilitative effects of safety behaviour, Rachman et al. (2008) 
suggested that safety behaviour may enhance the efficacy and acceptability of CBT by increasing 
perceptions of self-efficacy and control during treatment.  According to Bandura’s (1977) self-
efficacy theory, activities which diminish anxiety and promote a sense of mastery and control in 
threatening situations will reduce fear.  Based on this theory, it could be that safety behaviour 
enhances treatment efficacy by reducing anxiety and promoting perceptions of confidence and 
control during exposure.  Of course, it should be noted that these theories generally do not 
address the categorization of safety behaviour as adaptive versus maladaptive to treatment, and 




both theory and research support the notion that safety behaviour is highly idiosyncratic (e.g., 
Salkovkis et al., 1996), and thus cannot be considered a unitary construct.  As mentioned 
previously and discussed by Thwaites and Freeston (2005), efforts to properly categorize these 
behaviours are critical in order to inform cognitive-behavioural theory and research on safety 
behaviour.  
Treatment acceptability 
According to Rachman et al. (2008), the judicious use of safety behaviour may enhance 
the acceptability of CBT.  Treatment acceptability has been defined as the degree to which an 
individual perceives a treatment procedure to be fair, reasonable, appropriate, and un-intrusive 
for a given clinical problem (Kazdin, 1980; O’Brien & Karsh, 1991).  For anxiety and related 
disorders, previous research has shown that CBT is more acceptable than a variety of other 
treatments, including pharmacotherapy (Deacon & Abramowitz, 2005; Hofmann et al., 1998; 
Huppert, Franklin, & Foa, 2003), psychodynamic therapy (Becker, Darius, & Schaumberg, 
2007), and Gestalt therapy (Ertl & McNamara, 2000).  For instance, in a sample of individuals 
seeking treatment for anxiety disorders, vignette descriptions of CBT received higher 
acceptability ratings than vignette descriptions of pharmacotherapy (Deacon & Abramowitz, 
2005), even though a large number of participants in this study had a recent history of 
pharmacotherapy, not psychotherapy.  In a randomized-controlled trial comparing the efficacy of 
imipramine and CBT for panic disorder, Hofmann et al. (1998) reported that 103 (34%) 
participants declined to participate in the trial due to unwillingness to receive medication, as 
compared to only one (.3%) participant who declined due to unwillingness to receive CBT.  
Taken together, these findings suggest that CBT is the preferred treatment for anxiety and related 
disorders.  As such, it is surprising and unfortunate that so many treatment-seeking individuals 
refuse or drop out of CBT for anxiety problems, including ERP for OCD (e.g., Foa et al., 2005).  
As reviewed previously, the reasons for these high dropout rates are generally unknown, 
although preliminary evidence suggests that negative perceptions of exposure therapy may be 
one explanation.  Clearly more work is needed to enhance the acceptability of ERP and other 
exposure-based treatments, and the judicious use of safety behaviour may be a promising 
solution.   
Indeed, recent research has shown that vignette descriptions of CBT with the judicious 




descriptions of traditional CBT (Levy et al., 2014; Milosevic & Radomsky, 2013a).  To expand 
upon this work, Levy and Radomsky (2014) compared the acceptability of in vivo exposure to 
various contaminants with and without the use of safety behaviour and found higher 
acceptability and anticipated adherence ratings for the safety behaviour condition.  By contrast, 
Deacon et al. (2010) did not find differences in acceptability between traditional in vivo exposure 
and ESB for claustrophobic fear.  Overall, the findings support the acceptability-enhancing 
potential of safety behaviour in CBT, although more research is needed to clarify the mixed 
findings.  It could be that safety behaviour may enhance acceptability and promote treatment 
retention under certain conditions, such as among individuals with more severe anxiety problems 
(Rachman et al., 2008) or among clients/patients who failed to respond to ERP (Rachman et al., 
2011).  These are important questions that await future empirical attention.  For now, the initial 
promise that safety behaviour has shown in enhancing treatment acceptability warrants further 
investigation of its possible utility in CBT. 
Rationale and implications for the current program of research 
 In summary, most cognitive-behavioural models of anxiety disorders suggest that safety 
behaviour maintains anxiety by preventing disconfirmatory experiences.  However, empirical 
research on the effect of safety behaviour in CBT is inconclusive, suggesting that its use is not 
always counter-therapeutic.  Furthermore, recent studies support the notion that safety behaviour 
may be beneficial in treatment, both in terms of promoting cognitive change and enhancing 
treatment acceptability.  Unfortunately, to this author’s knowledge, there are currently no 
published guidelines for the judicious use of safety behaviour in CBT, and many questions 
remain about if, when, and/or how best to incorporate safety behaviour into existing treatments.  
For example, which kinds of safety behaviour may be beneficial in treatment, and which may be 
harmful?  Who should decide when to eliminate the safety behaviour during treatment, the 
client/patient or the therapist?  The current research program aimed to make a first attempt at 
addressing these questions.  Study 1 compared the efficacy and acceptability of exposure for 
contamination fear with different kinds of safety behaviours, classified by participants’ history of 
and experience with using them.  Study 2 examined the efficacy and acceptability of participant- 
and experimenter-initiated fading of safety behaviour during exposure to contamination-related 




 This research may have several implications for the cognitive-behavioural theory and 
treatment of anxiety and related problems.  First, the majority of previous studies on safety 
behaviour have employed undergraduate student samples, which limits the generalizeability of 
the findings to clinical samples.  As such, recruiting clinical and subclinical participants in the 
current research will address this gap in the literature, and thus may foster more direct 
implications for the theory and treatment of anxiety disorders.  Second, by attempting to 
elucidate the conditions under which safety behaviour may be beneficial versus detrimental to 
treatment, this series of studies may clarify mixed findings on the effects of safety behaviour in 
CBT.  Third, investigating the practical aspects of using safety behaviour in exposure bridges the 
gap between science and practice, and to this end may inform the development of novel 
cognitive-behavioural interventions for anxiety and related problems.    
Design 
Both studies were experimental in nature.  Study 1 investigated the efficacy and 
acceptability of exposure with different types of safety behaviour.  The design was mixed 
factorial, with between- and within-participants factors.  Clinical participants with 
contamination-related OCD were randomized to receive an exposure session for contamination 
fear with no safety aid (ERP), a routinely-used safety aid (RU), or a never-used safety aid (NU).  
Measures of contamination fear severity were administered before and after the exposure 
session, and perceptions of acceptability and anticipated adherence were assessed immediately 
following the session.  
Study 2 investigated the efficacy and acceptability of participant- and experimenter-
initiated fading of safety behaviour during exposure.  Similar to Study 1, the design was mixed 
factorial, with both between- and within-participants factors.  Undergraduate student participants 
with subclinical levels of contamination fear were assigned to receive an exposure session for 
contamination fear under one of three fading conditions: 1) participant-initiated, in which the 
participant decided when to eliminate the safety aid (PI condition); 2) experimenter-initiated, in 
which the timing of safety behaviour fading was yoked to the timing observed in the PI condition 
in order to control for time (ET condition); or 3) experimenter-initiated, in which safety 
behaviour fading was based on decreasing Subjective Units of Distress Scale (SUDS) ratings 
(ED condition).  As in Study 1, measures of contamination fear severity were administered at 





Study 1 tested three hypotheses: 1) exposure would be effective in reducing 
contamination fear severity across conditions; 2) the RU condition would demonstrate poorer 
treatment outcome as compared to the NU and ERP conditions; and 3) the NU and RU 
conditions would be rated as more acceptable than ERP.   
Study 2 tested two hypotheses: 1) the PI condition would demonstrate superior treatment 
outcome as compared to both the ET and the ED conditions; and 2) the PI condition would be 






ARE ALL SAFETY BEHAVIORS CREATED EQUAL? A COMPARISON OF NOVEL 
AND ROUTINELY-USED SAFETY BEHAVIORS IN  
OBSESSIVE-COMPULSIVE DISORDER 
Obsessive-compulsive disorder (OCD) is characterized by obsessions (i.e., recurrent, 
intrusive, and distressing thoughts) and/or compulsions (i.e., repetitive behaviors aimed at 
reducing anxiety; APA, 2013).  OCD is among the leading causes of disability worldwide 
(WHO, 2008), and individuals with OCD may often experience severe functional impairment 
and poor quality of life (Norberg, Calamari, Cohen, & Riemann, 2008).  Contamination fears and 
compulsive washing are common symptoms of OCD (Rachman, 2004; Rachman & Hodgson, 
1980), and may be less responsive to cognitive-behavioral therapy (CBT) than other OCD 
symptoms (Coelho & Whittal, 2001; McLean et al., 2001).  Therefore, it is important to foster 
the development of effective and acceptable treatments for contamination-related OCD.  As 
such, the purpose of the current study was to examine the efficacy and acceptability of a single 
session of exposure with safety behavior (ESB) for contamination fear.  To further the emerging 
research on ESB, in the present study we aimed to determine which (if any) kinds of safety 
behaviors may be beneficial versus detrimental to symptom reduction following a single-session 
experimental intervention.  
ESB was initially proposed as a potential solution for reducing problematic dropout rates 
in exposure-based treatments for anxiety disorders (Parrish, Radomsky, & Dugas, 2008; 
Rachman, Radomsky, & Shafran, 2008).  Although previous research strongly supports the 
efficacy of exposure and response prevention (ERP) for OCD (Deacon & Abramowitz, 2004; 
Foa et al., 2005; Franklin & Foa, 2011), 20-40% of individuals refuse the treatment entirely or 
drop out prematurely (Foa et al., 2005; Stanley & Turner, 1995; Whittal, Thordarson, & McLean, 
2005).  Despite the fact that this refusal and dropout rate is similar to that of CBT for other 
anxiety disorders (e.g., Hofmann & Smits, 2008), it suggests that a large number of 
clients/patients are not receiving effective treatment for their OCD.  Reasons for these 
problematic dropout rates are largely unknown.  In a longitudinal study of CBT utilization, 
Mancebo, Eisen, Sibrava, Dyck, and Rasmussen (2011) found that fear of CBT was a common 
reason for treatment refusal and/or dropout among individuals with OCD.  Thus, it is plausible 




exposure therapy is underutilized among practitioners; Becker, Zayfert, and Anderson (2004) 
surveyed 852 licensed doctoral level psychologists and found that only a minority were 
delivering exposure-based treatments to their anxious clients.  Commonly reported concerns 
among exposure therapists include client decompensation, symptom exacerbation, and premature 
termination (Deacon, Lickel, Farrell, Kemp, & Hipol, 2013).  Taken together, these findings 
suggest that practitioners as well as clients may have negative perceptions about exposure-based 
treatments for anxiety disorders.  
To address the dropout problem, Rachman et al. (2008) proposed that the judicious use of 
safety behavior, defined as the careful and strategic incorporation of safety behavior in the early 
and/or more challenging stages of treatment, may enhance the acceptability of exposure therapy 
and reduce treatment dropout rates.  Safety behaviors are overt or covert avoidance strategies 
used in threatening situations to reduce anxiety and/or prevent feared outcomes (Salkovskis, 
1991; Salkovskis, Clark, & Gelder, 1996).  Most current cognitive-behavioral models suggest 
that safety behavior maintains anxiety by interfering with threat disconfirmation, as individuals 
who use safety behavior in anxiety-provoking situations may falsely attribute the non-occurrence 
of feared outcomes to the presence of the safety behavior (Salkovskis, 1991; Salkovskis et al., 
1996).  However, empirical research investigating the effect of safety behavior on treatment 
outcome is inconclusive.  Several studies have shown that both the use (Kim, 2005; McManus, 
Sacadura, & Clark, 2008; Salkovskis, Clark, Hackmann, Wells, & Gelder, 1999) and availability 
(Powers, Smits, & Telch, 2004) of safety behavior undermines the efficacy of exposure-based 
treatments.  In contrast, other studies have found comparable outcomes following traditional 
exposure and ESB (Hood, Antony, Koerner, & Monson, 2010; van den Hout, Engelhard, 
Toffolo, & van Uijen, 2011; Milosevic & Radomsky, 2008, 2013a; Rachman, Shafran, 
Radomsky, & Zysk, 2011; Sy, Dixon, Lickel, Nelson, & Deacon, 2011).  Given the mixed 
findings, it is possible that safety behavior does not necessarily interfere with the efficacy of 
exposure.  
In fact, there may be some benefits to using safety behavior in CBT.  For instance, 
previous studies have shown that safety behavior enhances behavioral approach to feared stimuli 
during exposure (Milosevic & Radomsky, 2008, 2013a), which may facilitate the acquisition of 
disconfirmatory information.  Indeed, Milosevic and Radomsky (2013a) reported that spider-




demonstrated greater reductions in their targeted threat beliefs about spiders than participants 
who did not use safety gear.  Further, safety behavior has been shown to increase perceptions of 
control over distressing emotions (e.g., disgust) during exposure (van den Hout et al., 2011), 
which may also facilitate cognitive change in treatment.  With regard to acceptability, some 
research comparing the acceptability of CBT with and without safety behavior has found higher 
acceptability ratings for interventions incorporating safety behavior (Levy & Radomsky, 2014; 
Levy, Senn, & Radomsky, 2014; Milosevic & Radomsky, 2013b), whereas other studies have 
found no differences in acceptability ratings between traditional exposure and ESB (Deacon, Sy, 
Lickel, & Nelson, 2010).  Based on these studies, safety behavior may facilitate cognitive change 
and enhance treatment acceptability, both of which are important for effective treatment.  Of 
course, more research is needed to clarify the impact of safety behavior in CBT, particularly in 
light of mixed findings regarding treatment outcome and perceptions of acceptability.  
To the best of our knowledge, there are currently no published guidelines for the 
judicious use of safety behavior in CBT, and many questions remain about whether and/or how 
best to incorporate safety behavior into treatment.  For example, which kinds of safety behavior 
may be beneficial in treatment (e.g., promote behavioral approach), and which may be harmful 
(e.g., prevent threat disconfirmation)?  Several authors have addressed this question, yet there is 
no consensus about how best to classify safety behaviors as adaptive (e.g., used to facilitate 
approach behavior and/or the acquisition of helpful information) or maladaptive (e.g., used to 
prevent imagined catastrophes) coping strategies (Thwaites & Freeston, 2005).  For instance, 
Salkovskis et al. (1999) suggested that safety behaviors which are employed in order to avoid 
imagined disastrous consequences (e.g., contracting an illness) may be classified as maladaptive 
coping strategies that will interfere with disconfirmation.  Goetz and Lee (2015) recently 
proposed the classification of safety behavior as preventive (i.e., used to decrease the strength or 
intensity of exposure to a feared stimulus) or restorative (i.e., used to restore safety following 
exposure to a feared stimulus).  Another approach is to distinguish safety behaviors based on the 
degree to which they prevent the processing of disconfirmatory information (Telch & Lancaster, 
2012; Telch & Plasencia, 2010).  Of course, more information about how to appropriately 
classify these behaviors is critical to inform treatment development and delivery, as safety 
behaviors which are deemed maladaptive and/or likely to interfere with disconfirmation would 




In the present study, we approached the classification of safety behaviors as beneficial or 
detrimental to exposure based on their novelty.  In a clinical sample of individuals with 
contamination-related OCD, the efficacy of a single session of traditional exposure (ERP) was 
compared to a single session of exposure with one of two safety aids: one which the participant 
routinely uses (“RU” condition), or one which the participant has never used (“NU” condition).  
Due to their novelty, never-used safety aids may be less likely to interfere with treatment and 
cognitive change because they have not come to be associated with the prevention or avoidance 
of feared outcomes.  In fact, several studies demonstrating comparable outcomes following 
traditional exposure and ESB have provided participants with novel safety aids for use during 
exposure (e.g., “beekeeping equipment” as employed by Milosevic & Radomsky, 2008).  By 
contrast, the frequent use of routinely-used safety aids may have established an (erroneous) 
association between the presence of the safety aid and the non-occurrence of threatening 
outcomes, making them detrimental to treatment.  Furthermore, routinely-used safety aids 
employed by individuals with OCD are likely to be maintaining the anxiety problem, as the 
safety aids continue to be used despite the fact that anxiety persists and OCD symptoms remain.  
Finally, previous authors have suggested that the failure to find differences in outcome between 
exposure and ESB may be explained by poor ecological validity regarding safety behaviors 
provided by study experimenters and those commonly employed by anxious individuals (Hood et 
al., 2010; Telch & Lancaster, 2012).  As such, we felt it was important to examine the impact of 
routinely-used safety aids (which are, by nature, commonly employed by anxious individuals) on 
the efficacy of exposure.   
Our classification of safety behavior was different from other classification systems that 
have been proposed (e.g., Goetz & Lee, 2015), because the focus of the classification was on the 
novelty of the safety behavior (i.e., the frequency with which it is used), rather than the function 
of the safety behavior.  For example, Goetz and Lee (2015) classified tissues as “preventive” (not 
“restorative”) safety aids because they prevent contact with a feared contaminant; in the current 
experiment, tissues were classified based on the frequency with which they are used by a given 
participant in feared situations (i.e., regularly or never), irrespective of their preventive versus 
restorative properties.   
The current study tested three hypotheses: 1a) exposure would be effective in reducing 




exposure outcome as compared to the NU and ERP conditions; and 2) the two safety behavior 
conditions would be rated as more acceptable than ERP.  
Method 
Participants 
 After exclusions (see description below), participants were 57 individuals who met DSM-
IV diagnostic criteria for OCD and reported clinically-significant contamination fears and/or 
compulsive washing (i.e., greater than one hour spent thinking about contamination and/or 
engaging in washing behavior; APA, 2000).  Participants were recruited for a study evaluating a 
new treatment component for contamination fear via internet advertisements, flyers posted at 
Concordia University, and from a clinical registry of individuals who have previously 
participated in our research and agreed to be recontacted about future studies.   
 Of the 61 individuals who completed the diagnostic interview (see Measures), 60 met 
criteria for OCD and reported clinically-significant contamination fears and/or compulsive 
washing.  These 60 participants were randomized to condition (i.e., NU, RU, or ERP) via 
random selection of an index card containing the number one, two, or three from an envelope, 
and then completed the study.  Three participants were excluded (see description below), leaving 
a final sample of 57 participants.  The majority of the included participants was female (n = 34), 
ranging in age from 18 to 80 (M = 33.6, SD = 14.4) years.  Most participants identified their 
ethnic background as Caucasian (n = 34), with the rest identifying as Arab/West Asian (n = 6), 
South Asian (n = 4), Black (n = 3), Latin-American (n = 3), Other (n = 3), Chinese (n = 2), and 
South East Asian (n = 2).  Twenty-four participants reported that they had taken medication for 
psychological problems (either currently or in the past), including selective serotonin reuptake 
inhibitors (SSRIs; n = 16), serotonin norepinephrine reuptake inhibitors (SNRIs; n = 5), atypical 
antipsychotics (n = 3), benzodiazepines (n = 3), anticonvulsants (n = 3), sleep medication (n = 3), 
unspecified medication for anxiety and/or depression (n = 3), and psychostimulants (n = 1).  
Twenty-four participants reported having previously received psychotherapy.   
In terms of diagnostic status, most included participants had a primary diagnosis of OCD 
(n = 41), with the rest endorsing primary diagnoses of major depression (n = 4), generalized 
anxiety disorder (GAD; n = 4), specific phobia (n = 4), social anxiety disorder (SAD; n = 3), and 




to 6 (M = 1.2, SD = 1.1), and besides OCD (n = 16), the most common comorbid diagnoses were 
SAD (n = 20), GAD (n = 8), and specific phobia (n = 7). 
Measures 
Diagnostic interview.  Participants’ diagnoses were obtained using the Anxiety 
Disorders Interview Schedule for DSM-IV (ADIS-IV; Di Nardo, Brown, & Barlow, 1994), a 
semi-structured diagnostic interview that assesses the severity of anxiety, mood, substance use, 
somatoform, and psychotic disorders on a 9-point scale ranging from 0 (none) to 8 (very severe).  
The ADIS-IV has demonstrated adequate to excellent inter-rater reliability (r = .68-.99; Tsao, 
Lewin, & Craske, 1998) and retest reliability (Di Nardo, Moras, Barlow, Rapee, & Brown, 
1993).  In the current study, the ADIS-IV was administered in order to confirm OCD diagnosis 
and to assess for the presence of contamination fear and/or compulsive washing symptoms.  The 
interview was administered by a well-trained senior doctoral student in clinical psychology, who 
was blind to condition assignment at the time of the interview.  To ensure diagnostic reliability 
with regard to the primary eligibility criteria for the study (i.e., presence of OCD diagnosis and 
clinically-significant contamination fears and/or compulsive washing), an independent rater 
listened to 20% of audio recordings of the diagnostic interview and coded the presence or 
absence of OCD diagnosis and the severity of contamination fears and/or compulsive washing.  
This independent rater was a research assistant with a bachelor’s degree in psychology and over 
10 years of experience administering the ADIS-IV and other semi-structured interviews to 
clinical participants.  There was 100% agreement across raters for the presence of OCD 
diagnosis and the severity of contamination fear (severity ratings across raters were within one 
point of each other on the ADIS-IV severity scale). 
Behavioral approach test (BAT).  The BAT is a commonly used behavioral index of 
fear.  In the current study, participants were asked to approach a “dirty” bedpan (i.e., a bedpan 
filled with water and yellow food coloring; see Materials) as close as they were able on an 18-
point hierarchy, ranging from standing outside the room containing the bedpan with the door 
closed to touching the inside rim of the bedpan with both hands and then touching one’s arms 
and chest.  This BAT was adapted from previous research on compulsive washing behavior 
(Cougle, Wolitzy-Taylor, Lee, & Telch, 2007; Najmi, Tobin, & Amir, 2012).  Participants 
completed the BAT before and after the exposure session, in order to assess changes in 




the exposure session) stimulus.  Participants were not permitted to use safety aids during the 
BATs.  The BAT was administered by a well-trained undergraduate student in psychology who 
was blind to condition.  To ensure that this independent evaluator remained blind to condition 
assignment for the duration of the study, the experimenter did not speak about the study or 
provide any details about the exposure session until after the post-exposure BAT was completed.   
Self-report measures.  The following self-report measures were also administered.  
Contamination fear.  Participants completed the Vancouver Obsessional Compulsive 
Inventory (VOCI; Radomsky et al., 2006; Thordarson et al., 2004), which is a 55-item 
questionnaire that assesses the severity of OCD symptoms.  Participants are asked to rate the 
degree to which the items are true of them on a 5-point Likert scale (0 = not at all and 4 = very 
much).  The VOCI has demonstrated excellent internal consistency in student (α = .96) and 
clinical (α = .94) samples, as well as convergent and divergent validity (Radomsky et al., 2006; 
Thordarson et al., 2004).  For the purposes of the current study, only the 12-item contamination 
subscale of the VOCI (“VOCI-Contamination”) was included in the analyses in order to assess 
changes in contamination fear severity from pre- to post-exposure, and it demonstrated adequate 
internal consistency at both time points (pre-exposure α = .84; post-exposure α = .86). 
Subjective distress.  The Subjective Units of Distress Scale (SUDS; Wolpe, 1958) is a 
measure of subjective fear during behavior therapy.  Participants are asked to rate their level of 
subjective distress on a scale from 0 (neutral) to 100 (worst distress you can imagine).  In this 
study, the SUDS was administered at two time points during the BAT (i.e., before approaching 
the contaminant, the Anticipatory SUDS rating, and after approaching the contaminant, the Peak 
SUDS rating), in order to assess pre- to post-exposure changes in subjective distress when in the 
presence of an independent (i.e., not used during the exposure session) stimulus.  The SUDS was 
administered by the independent evaluator who was blind to condition (see above). 
Treatment acceptability.  Participants completed the Treatment Acceptability/Adherence 
Scale (TAAS; Milosevic, Levy, Alcolado, & Radomsky, in press), which is a 10-item scale that 
assesses acceptability of and anticipated adherence to a given treatment.  Participants are asked 
to rate their agreement with several statements about the treatment on a 7-point Likert scale (1 = 
disagree strongly and 7 = agree strongly).  For the purposes of the current study, the TAAS was 
administered following the exposure session, and when completing the TAAS, participants were 




complete treatment package (i.e., several exposure sessions, instead of just one).  The TAAS was 
chosen as the measure of acceptability in the current study because it assesses acceptability and 
anticipated adherence, both of which we felt were important to assess given that Rachman et al. 
(2008) proposed that safety behavior may enhance acceptability and reduce dropout in exposure-
based treatments for anxiety disorders.  The TAAS showed adequate internal consistency in the 
current sample (α = .81). 
Materials 
 Contaminants.  Prior to the exposure session, participants were presented with six 
contaminants, including rummaging through a partly filled garbage basket containing crumpled 
paper towels, tissues, and food wrappers; handling old and worn bills and coins; rubbing the 
bottom of their shoes; handling an old grimy telephone; handling a test tube labeled “PATH 194” 
containing red food coloring, which was housed inside a sealed biohazard bag; and handling 
discarded laboratory materials (e.g., a urine cup), contained inside a sealed biohazard bag.  
Similar contaminants have been used in previous research on exposure-based treatment for 
contamination fear (van den Hout et al., 2011; Rachman et al., 2011).  Participants were asked to 
touch the six contaminants in random order and to rate their SUDS while touching each 
contaminant.  The object that evoked the highest SUDS level was used in the exposure session. 
Safety aids.  All participants were asked to bring a routine safety aid to the laboratory 
(see Participants), and if randomized into the RU condition, they were told to use this safety aid 
during the exposure session.  If participants brought more than one safety aid to the laboratory, 
they were asked to indicate which one is most important for them to have when feeling anxious 
about contamination, and told to use this safety aid during the exposure session.  If randomized 
into the NU condition, participants were offered a safety aid that they did not routinely use, that 
was different from the one they brought in with them.  For instance, a participant who brought 
hand sanitizer to the laboratory may have been offered hygienic wipes to use during the exposure 
session.  To assign this safety aid, several names of safety aids (all of which were different from 
the one the participant brought in; e.g., gloves, hygienic wipes) were placed in a hat and then one 
was chosen at random.  Preliminary analyses revealed that the assigned safety aids were indeed 
“never used” (see Manipulation Check, below).  If randomized to ERP, participants were not 




“Dirty” bedpan.  A bedpan filled with water and yellow food coloring was used as the 
contaminant for the pre- and post-exposure BATs.  A similar contaminant has been used in 
previous research on contamination fear (Levy & Radomsky, 2014; Olatunji, Lohr, Sawchuck, & 
Tolin, 2007).  Prior to completing the BAT, participants were told “inside this room 
[independent evaluator pointed to the testing room] is a dirty bedpan”. 
Procedure  
Prior to participating, interested individuals completed a telephone screen during which 
they were asked standardized questions about contamination fears and washing behavior, 
depressive symptoms and suicidal ideation, current mania and psychosis, and current substance 
abuse.  The phone screen also assessed routine use of overt safety behavior with the following 
question: “When you are feeling anxious or fearful about contamination or germs, is there 
anything you do to feel more comfortable?  For instance, some people like to always have hand 
sanitizer on them to use in case they feel contaminated.  Is there anything like this that you do?”  
Participants were then asked to describe the nature and use of their overt safety aids.  Callers 
who endorsed clinically-significant contamination fears and/or compulsive washing and routine 
use of overt safety aids (defined as frequent use of one or more safety aids and/or at least one 
safety aid is usually or always with them when they go out) and who denied current symptoms of 
mania and psychosis were invited to participate in the study, and were asked to bring their safety 
aid(s) along with them to the laboratory.   
Following the informed consent process, participants completed the ADIS-IV with the 
experimenter, and eligible participants (see Participants) were then asked to complete a battery of 
self-report questionnaires, including a demographics questionnaire and the VOCI-
Contamination.  They then completed the pre-exposure BAT with the independent evaluator who 
was blind to condition.  After the BAT, participants were randomized to condition and presented 
with the six contaminants (see Materials).  Once the most distressing contaminant was chosen, 
participants were provided with a description of and rationale for exposure therapy, and were 
then told that “exposure can be conducted with or without safety aids, or objects that help people 
to feel more comfortable when they are anxious, like the [name of routinely-used safety aid] you 
brought in today.  Safety aids may or may not be helpful during exposure.  Some researchers 
think that they prevent people from overcoming their fears, and others think that they help people 




of the safety behavior conditions, the rationale continued as follows: “You have been assigned to 
the condition where you will use [your own safety aid/a safety aid that we provide] during the 
exposure session”.  If this was the ERP condition, the rationale continued with, “You have been 
assigned to the condition where you will not use any safety aids during the exposure session”.   
Participants then completed the exposure session, which involved 20 exposure trials to 
the chosen contaminant.  Each trial consisted of touching the contaminant, either with (RU or 
NU condition) or without (ERP) a safety aid, and then waiting for a 30-second delay prior to the 
next trial (modeled after previous research; see van den Hout et al., 2011 and Rachman et al., 
2011).  Following the session, participants completed the TAAS and were then given a short 
break during which they were told to read magazines in the testing room.  After the break, 
participants completed the VOCI-Contamination and the post-exposure BAT with the 
independent evaluator.  They were then fully debriefed, informed that the “contaminants” were 
not actually contaminated, and compensated $40 for their participation.  
Statistical Analyses 
To assess baseline comparability of groups, a series of one-way analyses of variance 
(ANOVAs) were conducted on the demographic variables and on the following pre-exposure 
measures: ADIS-IV OCD severity, VOCI-Contamination, BAT, and SUDS ratings.  These 
analyses revealed several baseline differences (see below).  To test the first hypothesis 
concerning overall exposure efficacy, a series of 3 x 2 (condition x time) mixed ANOVAs were 
conducted on VOCI-Contamination, BAT, and SUDS ratings at pre- and post-exposure.  To test 
the second hypothesis concerning between-condition differences in outcome, a series of one-way 
analyses of covariance (ANCOVAs) were conducted on each of the dependent variables at post-
exposure, controlling for the corresponding pre-exposure variable (i.e., to control for baseline 
differences, see below).  To test the third hypothesis concerning between-condition differences in 
treatment acceptability, a one-way ANOVA was conducted on TAAS scores. 
Results 
Exclusions 
 Three participants were excluded for the following reasons: one participant in the ERP 
condition refused to complete 20 exposure trials; one participant in the RU condition did not 
adequately engage with the exposure session (e.g., kept eyes closed to avoid looking at the 




These events occurred during the exposure session (i.e., after randomization to condition).  These 
three participants were excluded from the analyses, leaving a final sample of 57 participants (n = 
19 per condition). 
Safety Aids 
 The following safety aids were brought in by participants assigned to the RU condition 
and used for the duration of the exposure session: hand sanitizer (n = 12), hygienic wipes (n = 4), 
tissues (n = 2), and gloves (n = 1).  The following safety aids were assigned to participants 
randomized to the NU condition and used for the duration of the exposure session: latex-free 
gloves (n = 8), hygienic wipes (n = 5), tissues (n = 5), and hand sanitizer (n = 1).  Hygienic wipes 
and hand sanitizer were used after each touch, whereas gloves and tissues were used during each 
touch (i.e., to prevent contact with the contaminant).  All participants in the ERP condition 
complied with instructions and did not use any safety aids during the exposure session. 
Manipulation Check  
 To ensure that the assigned safety aid was indeed “never used”, all participants in the NU 
condition were asked to indicate how often they used the assigned safety aid when they are 
feeling anxious about contamination in a typical week.  As intended, most participants reported 
that they never used the assigned aid (n = 15), with the others reporting that they rarely (n = 2) or 
sometimes (n = 2) used the aid.   
Group Comparisons at Pre-Exposure 
 Groups did not differ with respect to age [F(2, 54) = .31, p = .739] or sex [X
2
(2) = 1.02, p 
= .600].  There was a trend for group differences on previous pharmacological treatment [X
2
(2) = 
5.61, p = .060], and significant group differences on previous psychotherapy [X
2
(2) = 8.21, p = 
.017].  Despite random assignment, groups significantly differed on all baseline symptom 
measures (all Fs > 3.65, all ps < .05), and there was a trend for mean differences on VOCI-
Contamination scores, F(2, 54) = 2.83, p = .068.  See Table 1 for means and standard deviations 
of all symptom measures at pre- and post-exposure, including mean comparisons of baseline 


























































































































Note.  ADIS-IV = Severity of Obsessive-Compulsive Disorder as measured by the Anxiety 
Disorders Interview Schedule for DSM-IV.  Comorbid = Number of comorbid diagnoses.  
VOCI-C = Vancouver Obsessional Compulsive Inventory – contamination subscale.  BAT = 
Behavioral approach test.  SUDS = Subjective Units of Distress Scale.  ERP = Exposure and 
response prevention.  Post-exposure means are corrected for the corresponding pre-exposure 
variable.  Means with unshared subscripts in each row at a given time point are significantly 
different from each other at that time point, p < .05.   
Asterisks denote significant main effects of time on a given variable, *p < .001.   
Exposure Outcome (Hypothesis 1a and 1b) 
Within-participants effects.  A series of 3 x 2 (condition x time) mixed ANOVAs 
revealed significant main effects of time on all measures, including VOCI-Contamination, F(1, 
54) = 13.89, p < .001, ηp
2 
= .21, BAT, F(1, 54) = 20.05, p < .001, ηp
2
 = .27, and SUDS 
[Anticipatory, F(1, 54) = 12.49, p = .001, ηp
2
 = .19; Peak, F(1, 54) = 45.57, p < .001, ηp
2
 = .45; 
see Table 1] such that in general, contamination-related symptomatology and behavior 




Between-participants effects.  Due to baseline differences in symptom severity (see 
above), the following analyses were conducted while controlling for the corresponding pre-
exposure variable.  One-way ANCOVA on post-exposure VOCI-Contamination scores while 
controlling for pre-exposure VOCI-Contamination revealed a trend for a main effect of 
condition, F(2, 53) = 2.73, p = .075, ηp
2
 = .09.  Similarly, one-way ANCOVA on post-exposure 
Peak SUDS while controlling for pre-exposure Peak SUDS revealed a trend for a main effect of 
condition, F(2, 53) = 2.64, p = .081, ηp
2
 = .09.  There were no condition differences on post-
exposure Anticipatory SUDS or post-exposure BAT (both Fs < 1.80, both ps > .05, both ηp
2
s < 
.07) while controlling for pre-exposure values.   
Follow-up pairwise comparisons on post-exposure VOCI-Contamination scores revealed 
a significant difference between NU (M = 24.00, SD = 6.68) and RU [M = 31.11, SD = 9.29; F(1, 
35) = 4.91, p = .033, ηp
2
 = .12], and between NU and ERP [M = 31.84, SD = 7.40; F(1, 35) = 
4.56, p = .040, ηp
2
 = .12], but no difference between RU and ERP, F(1, 35) = .18, p = .672, ηp
2
 = 
.01.  On post-exposure Peak SUDS, there was a significant difference between NU (M = 32.00, 
SD = 26.16) and RU [M = 58.95, SD = 28.31; F(1, 35) = 4.72, p = .037, ηp
2
 = .12], but no 
differences between NU and ERP [M = 55.00, SD = 24.15; F(1, 35) = 2.55, p = .120, ηp
2
 = .07] 
or between RU and ERP, F(1, 35) = .68, p = .416, ηp
2
 = .02.  See Table 1 for means and standard 
deviations of all symptom measures at post-exposure, corrected for pre-exposure scores
1
.  
Treatment Acceptability (Hypothesis 2) 
 A one-way ANOVA revealed a marginal condition difference in TAAS scores, F(2, 54) = 
2.70, p = .076, ηp
2
 = .09.  Pairwise comparisons showed marginally higher TAAS scores for the 
NU condition (M = 53.26, SD = 8.32) as compared to the RU condition [M = 48.32, SD = 6.77; 
F(1, 36) = 4.04, p = .052, ηp
2
 = .10], marginally higher TAAS scores for the NU condition as 
compared to ERP [M = 46.79, SD = 11.27; F(1, 36) = 4.06, p = .052, ηp
2
 = .10], and no 




The purpose of this study was to examine the impact of routinely-used versus never-used 
safety aids on a single session of exposure to contamination.  Participants with OCD and 
                                                 
1
 These analyses were repeated without the covariates as a series of 3 x 2 (condition x time) mixed ANOVAs.  These 
analyses revealed significant main effects of condition on BAT, F(2, 54) = 5.07, p = .010, ηp
2
 = .16, Anticipatory 
SUDS, F(2, 54) = 5.26, p = .008, ηp
2
 = .16, Peak SUDS, F(2, 54) = 6.11, p = .004, ηp
2
 = .18, and VOCI-
Contamination, F(2, 54) = 4.84, p = .012, ηp
2




contamination fear were randomized to receive an exposure session with no safety aid (ERP), a 
never-used safety aid (NU), or a routinely-used safety aid (RU).  To the best of our knowledge, 
this is the first study to investigate the efficacy of ESB among clinically-anxious individuals with 
a diagnosis of (contamination-related) OCD.  Consistent with hypotheses, all groups 
demonstrated improvement in terms of contamination fear severity, behavioral approach to the 
contaminant, and subjective anxiety ratings.  However, participants in the NU condition had the 
lowest self-reported contamination fear severity at post-exposure, as well as significantly lower 
peak fear ratings than participants in the RU condition.  NU also received marginally higher 
treatment acceptability and anticipated adherence ratings than RU and ERP.  Overall, the 
findings suggest that there may be subtle yet potentially important differences in outcome and 
acceptability when incorporating different kinds of safety aids into exposure-based treatments.  
However, these results should be interpreted with caution due to baseline differences in symptom 
severity.  
It was hypothesized that exposure would be effective in reducing contamination fear 
severity across conditions.  This hypothesis was supported, as all conditions demonstrated 
improvement on measures of contamination fear severity, behavioral approach to the 
contaminant, and subjective anxiety ratings.  It was further hypothesized that the RU condition 
would demonstrate poorer exposure outcome as compared to the NU and ERP conditions.  This 
hypothesis was partially supported.  Controlling for baseline differences in contamination fear 
severity, participants in the RU condition demonstrated greater contamination fear severity and 
peak fear at post-exposure than those in the NU condition.  Consistent with hypotheses, these 
results suggest that a single session of exposure with routinely-used safety aids may be less 
effective than exposure with novel (i.e., never used) safety aids.  Poorer exposure outcome in RU 
as compared to NU may be explained by the frequency with which routinely-used safety aids are 
employed in threatening situations.  Indeed, repetitive use of these safety aids may lead the 
individual to falsely conclude that the safety aids themselves prevented a feared outcome from 
occurring, thus blocking the acquisition of accurate threat-relevant information.  By contrast, 
novel safety aids, which have never been employed in threatening situations to manage anxiety 
and/or prevent feared outcomes, may not have the same potential to prevent disconfirmatory 
experiences.  On the other hand, RU was comparable to NU on other measures of symptom 




contaminant.  As such, it is unclear whether routinely-used safety aids actually interfere with the 
efficacy of a single session of exposure.  These findings contrast with cognitive-behavioral 
theory on safety behavior, which suggests that any safety aid (novel and routinely-used alike) 
that is employed in feared situations in order to reduce anxiety and/or prevent feared outcomes 
will undermine cognitive change and treatment efficacy (e.g., Salkovskis et al., 1996).  Future 
research is needed to clarify inconsistent findings regarding the impact of routinely-used safety 
aids in this study, particularly in the absence of baseline differences.   
Contrary to hypotheses, RU was generally comparable to ERP at post-exposure, although 
the results should be interpreted with caution given the observed baseline differences.  Indeed, 
participants in the RU condition demonstrated similar contamination fear severity, subjective 
fear ratings, and behavioral approach to the contaminant at post-exposure than participants in 
ERP.  This is a surprising and noteworthy finding, as cognitive-behavioral theory suggests that 
safety behavior maintains anxiety via misattributions of safety in anxiety-provoking situations.  
In particular, safety aids which are employed in order to avoid imagined catastrophes (e.g., 
illness, disease) will prevent cognitive change (Salkovskis, 1991; Salkovskis et al., 1996).  Based 
on our results, routinely-used safety aids may not necessarily undermine the efficacy of 
traditional exposure, at least in a single-session intervention.  Although unexpected, these 
findings are consistent with previous research comparing traditional exposure and ESB and 
finding no differences (e.g., Hood et al., 2010; van den Hout et al., 2011; Milosevic & 
Radomsky, 2008).  A closer look at cognitive-behavioral theory on safety behavior may explain 
these results.  Rachman et al. (2008) proposed that any safety behavior, when used strategically 
in treatment, may enhance treatment efficacy and acceptability by providing an increased sense 
of control over the exposure session.  In fact, the authors specified that “the prospect of using 
their own [emphasis added] or the therapist’s recommended safety tactics can help to provide 
that sense of control and increased predictability” (p. 541).  As such, participants in the RU 
condition may have felt increased control when using their safety aids during the exposure 
session, which may have contributed to the efficacy of the intervention. 
Alternatively, inhibitory learning theory may explain these findings.  As described by 
Craske et al. (2014), the degree to which safety behavior interferes with inhibitory learning (i.e., 
the development of new non-threat associations; Craske et al., 2008) depends on the strength of 




anxiety.  As such, it could be that RU was effective because the exposure session was still potent 
enough to elicit the fear response, and thus, make it possible for corrective learning to occur.  Of 
course, to our knowledge this is the first study to examine the impact of routinely-used safety 
aids on the efficacy of exposure, and thus further replication and extension of our findings, 
especially over a longer course of intervention and follow-up, will be important.  The degree to 
which safety behavior enhances perceived control and/or inhibitory learning was not assessed in 
the current study, and baseline differences may have impacted the results. 
Contrary to cognitive-behavioral theory (e.g., Salkovskis et al., 1996) and some 
experimental research (e.g., McManus et al., 2008; Powers et al., 2004), NU was generally 
comparable to ERP at post-exposure.  Specifically, participants in the NU condition had 
significantly lower VOCI-Contamination scores following the exposure session than participants 
in the ERP group, and comparable scores on all other outcome measures (i.e., subjective fear, 
behavioral approach).  Overall, these findings suggest that exposure with safety behavior may be 
comparably effective to traditional exposure.  These results are consistent with cognitive-
behavioral theory on the potential benefits of using safety behavior in CBT (Parrish et al., 2008; 
Rachman et al., 2008), as well as recent research demonstrating comparable outcomes in 
traditional exposure as compared to ESB (e.g., Hood et al., 2010; Rachman et al., 2011; Sy et al., 
2011).  Taken together, these studies support the notion that safety behavior is not necessarily 
detrimental to treatment, and may be facilitative in certain cases (e.g., in reducing self-reported 
contamination fear severity, as in the current research).  The current study has the potential to 
contribute to previous work by aiming to determine which safety aids may be beneficial versus 
detrimental to exposure.  Indeed, to our knowledge only one previous study has attempted to 
distinguish between different types of safety aids and their impact on treatment outcome (see 
Goetz & Lee, 2015).  Based on the results of the current study, novel safety aids may be most 
appropriate for use in exposure, although mixed findings regarding the impact of routinely-used 
safety aids preclude any substantive conclusions.  Replication and extension of the findings over 
a longer period of intervention and follow-up is needed to clarify these results.  Furthermore, it 
should be noted that although we were interested in the novelty of the safety behavior in this 
study (i.e., the frequency with which it was previously used by participants), rather than the 
specific function or type of safety behavior, it is possible that the use of different kinds of safety 




used hand sanitizer during the exposure session, while the majority of participants in NU were 
given latex-free gloves for the exposure.  To use the terminology of Goetz and Lee (2015), most 
individuals in the RU group employed “restorative” safety aids during exposure, whereas most of 
those in NU were given “preventive” safety aids.  Given that these authors found differences in 
exposure outcome as a function of “restorative” versus “preventive” safety aids, it will be 
important to extend the current study by controlling for this potential confound (e.g., by 
matching safety aids across conditions), although this may be challenging due to the 
idiosyncratic nature of safety behavior (Salkovskis et al., 1996).  Our prediction would be that 
although “restorative” safety aids might be more helpful than “preventative” safety aids, both 
types could be useful in facilitating disconfirmatory experiences, depending upon the beliefs held 
by each individual participant/client. 
 It was hypothesized that the safety behavior conditions would be rated as more 
acceptable than ERP.  This hypothesis was partially supported, as anticipated adherence ratings 
were marginally higher in the NU condition as compared to ERP.  These findings are in partial 
support of Rachman et al. (2008), who proposed that safety behavior may enhance the 
acceptability of exposure-based treatments, as well as recent research demonstrating that CBT 
with safety behavior is rated as more acceptable than traditional CBT (Levy & Radomky, 2014; 
Levy et al., 2014; Milosevic & Radomsky, 2013b).  Taken together, these results indicate that 
safety behavior may enhance the acceptability of CBT, at least in a brief intervention.  Although 
we did not find significant differences in treatment acceptability between NU and ERP, the 
pattern of exclusions in the current study may lend additional support to our hypotheses.  Indeed, 
the only participant who refused to complete the exposure session was assigned to the ERP 
condition, suggesting that perhaps this individual found the exposure session particularly 
distressing and intolerable.  By contrast, the participant who was excluded from the NU 
condition elected not to use the assigned safety aid, but otherwise completed the exposure 
session without complaint.  Nevertheless, further replication and extension of these findings will 
be critical, as a single-session exposure does not provide adequate information about the 
acceptability of a complete CBT protocol.  Furthermore, it will be interesting to examine the 
impact of prior pharmacotherapy and psychotherapy (particularly CBT) on perceptions of 
treatment acceptability, which was not assessed in the current study.  Our previous work (Levy et 




actually reduce treatment acceptability and anticipated adherence, and so it will be important to 
further investigate these associations.   
 The current study had several limitations.  First, given our sample size, we may have 
been underpowered to detect condition differences in outcome and acceptability, although an a 
priori power analysis suggested that a sample size of 57 was sufficient to test our hypotheses.  
Indeed, it should be noted that the results of our omnibus tests were only marginally significant, 
although follow-up pairwise comparisons revealed significant differences on certain outcome 
measures.  We were also unable to compare the conditions on other potentially important 
outcome variables, such as disgust (e.g., Olatunji, Sawchuk, Lohr, & de Jong, 2004) and mental 
(non contact-based) contamination (e.g., Rachman, 2004; Rachman, Coughtrey, Shafran & 
Radomsky, 2015).  Furthermore, baseline differences on most measures of symptom severity 
may have impacted our findings, although we attempted to control for these differences in all 
between-groups analyses.  As such, replication and extension of this work will be important, 
particularly in the absence of baseline differences.  Second, the single-session delivery of 
exposure in this study is inadequate to assess definitively treatment outcome and/or perceptions 
of acceptability.  Similarly, in clinical practice CBT therapists commonly provide lengthy 
rationales for exposure therapy and safety behavior elimination, which could not be provided in a 
brief experiment such as this one.  Although it will be significantly more resource intensive, 
future research should investigate the efficacy and acceptability of a comprehensive CBT 
protocol (including an adequate treatment rationale) varying in safety aids.  A related limitation 
is the absence of a follow-up period, which did not allow us to assess maintenance of gains.  
Although previous studies comparing exposure with and without safety behavior have not found 
differences in outcome after a follow-up period (e.g., van den Hout et al., 2011), we cannot 
assume that our results would have demonstrated stability over time.  Third, we did not assess 
the impact of covert (subtle) safety behaviors on exposure outcome, and it is possible that the use 
of these behaviors impacted our findings.  Finally, the judicious use of safety behavior involves 
the incorporation of safety aids into the early and/or more challenging stages of treatment and 
then fading them out over the course of treatment (Rachman et al., 2008).  Given that the current 
study used a single-session design, we were unable to assess the efficacy and acceptability of 
exposure with safety behavior fading.  Despite these limitations, to our knowledge this is the first 




individuals diagnosed with OCD.  Consistent with previous work, our findings suggest that 
safety behavior may not interfere with a single-session exposure, and certain safety aids (i.e., 







 Contrary to traditional cognitive-behavioural theory pertaining to safety behaviour 
(Salkovkis, 1991; Salkovskis et al., 1996), experimental research examining the impact of safety 
behaviour on treatment outcome is inconclusive.  Some studies suggest that safety behaviour 
undermines the efficacy of exposure-based treatments (e.g., Kim, 2005; Salkovskis et al., 1999), 
whereas other research has failed to find a deleterious effect of safety behaviour on treatment 
outcome (e.g., Milosevic & Radomsky, 2008, 2013b; Rachman et al., 2011).  Furthermore, 
emerging research indicates that safety behaviour may actually improve outcomes in CBT by 
enhancing treatment acceptability (e.g., Levy & Radomsky, 2014) and cognitive change (e.g., 
Milosevic & Radomsky, 2013b).  However, further research on safety behaviour in CBT is 
hampered by the absence of practical guidelines for the incorporation of safety behaviour into 
existing treatments.  For instance, which kinds of safety behaviour should be used in treatment?  
Are there certain safety aids that are more likely to undermine the efficacy of exposure than 
others? 
 Study 1 was designed to inform our understanding of which kinds of safety aids should 
be considered during exposure for anxiety-related problems.  Based on cognitive-behavioural 
theory (e.g., Salkovskis, 1991; Salkovskis et al., 1996), it follows that routinely-used safety aids 
may be likely to undermine the efficacy of exposure, as their continued use may have established 
an incorrect association between the presence of the safety aid and the non-occurrence of 
negative outcomes.  By contrast, a novel safety aid, which has never been employed in a 
threatening situation to prevent or avoid feared outcomes, may not have the same potential to 
prevent disconfirmatory experiences.  To test this hypothesis, clinical participants with 
contamination-related OCD were randomized to complete an exposure session with no safety aid 
(ERP), a routinely-used safety aid (RU), or a never-used safety aid (NU).  Results demonstrated 
significant pre- to post-exposure reductions in contamination fear severity across conditions.  
However, participants in the NU condition demonstrated the lowest self-reported contamination 
fear severity at post-treatment, and the NU condition received the highest acceptability and 
anticipated adherence ratings.  Contrary to traditional cognitive-behavioural theory (Salkovskis, 
1991; Salkovskis et al., 1996) but consistent with recent literature (e.g., Rachman et al., 2011), 




findings suggest that novel safety aids may be the most appropriate choice for use in exposure-
based treatment.   
In addition to which kinds of safety behaviour to use, other practical questions 
concerning the use and fading of safety behaviour remain.  For example, who should decide 
when to eliminate the safety behaviour during treatment, the client or the therapist?  According 
to Rachman et al. (2008), the judicious use of safety behaviour is the careful and strategic 
implementation of safety behaviour, “with an emphasis on the early stages of treatment” (p. 
169).  Despite the fact that this definition of “judicious use” implies that safety behaviour is used 
in the beginning of treatment and then removed, specific guidelines for how to eliminate the 
safety behaviour are not provided.  Of course, these guidelines, ideally stemming from an 
evidence base, are needed in order to inform clinical practice and future research on safety 
behaviour.  As such, Study 2 was designed to address this next question concerning the practice 
of safety behaviour fading.  Participants with subclinical levels of contamination fear were 
assigned to complete an exposure session under one of three fading conditions: 1) participant-
initiated (PI condition); 2) experimenter-initiated, which was yoked to the PI condition in order 
to control for time (ET condition); and 3) experimenter-initiated, which was based on decreasing 
subjective distress ratings (ED condition).  According to self-efficacy theory (Bandura, 1977, 
1988), activities which promote a sense of confidence and control in threatening situations will 
reduce fear and avoidance behaviour.  As such, perhaps allowing participants to decide when to 
eliminate the safety behaviour may promote perceptions of self-efficacy and control, thus 
increasing treatment efficacy and acceptability.  From self-efficacy theory, it was hypothesized 
that the PI condition would demonstrate superior treatment outcome and greater treatment 













IT’S THE WHO NOT THE WHEN: AN INVESTIGATION OF SAFETY BEHAVIOR 
FADING IN EXPOSURE TO CONTAMINATION 
Obsessive-compulsive disorder (OCD) is a common and often severe psychological 
disorder, which affects 1-2% of the population (Kessler et al., 2005).  Cognitive-behavioral 
therapy (CBT) that incorporates exposure and response prevention (ERP) is an effective 
treatment for OCD (e.g., Deacon & Abramowitz, 2004; Foa et al., 2005; Franklin & Foa, 1998, 
2011), which involves repeated and prolonged exposure to feared stimuli while refraining from 
engaging in compulsive behavior.  Despite the fact that ERP is considered by some to be the 
“gold standard” treatment for OCD (March, Frances, Carpenter, & Kahn, 1997), an unacceptably 
high number of treatment-seeking individuals refuse this treatment entirely or drop out 
prematurely (Cottraux et al., 2001; Foa et al., 2005; Stanley & Turner, 1995; Whittal, 
Thordarson, & McLean, 2005).  For example, in a randomized-controlled trial comparing the 
efficacy of clomipramine and ERP, Foa et al. (2005) reported that 22% of participants withdrew 
from the study upon randomization into the ERP condition, and an additional 28% dropped out 
during ERP.  Moreover, 23% of participants in this study withdrew upon randomization into 
clomipramine, and an additional 25% dropped out during clomipramine treatment.  In another 
study comparing the efficacy of ERP and cognitive therapy for OCD, Cottraux et al. (2001) 
reported that 30% of participants dropped out of the ERP condition, as compared to 22% who 
dropped out of cognitive therapy.  Taken together, these studies suggest that ERP has relatively 
similar dropout rates to other effective treatments.  Nevertheless, these rates represent a 
significant dissemination and utilization problem, and suggest that a large number of OCD 
sufferers are not receiving effective treatment for their OCD. 
As such, recent literature has focused on potential ways in which to increase the 
acceptability of ERP without detracting from its efficacy.  Rachman, Radomsky, and Shafran 
(2008) proposed that the judicious use of safety behavior, defined as the careful and strategic 
incorporation of safety behavior into the early and/or more challenging stages of treatment, may 
enhance the acceptability of CBT.  However, exactly how to fade safety behavior during 
treatment is unclear from this definition of “judicious use”.  The current study aimed to address 
this question by examining the efficacy and acceptability of participant- and experimenter-




credible research on safety behavior in CBT can be conducted, it will be important to 
operationalize and define the practice of safety behavior fading. 
Safety behavior has been defined as overt or covert avoidance strategies that are 
employed in anxiety-provoking situations to reduce anxiety and/or minimize perceived threat 
(Salkovskis, 1991; Salkovskis, Clark, & Gelder, 1996).  According to most cognitive-behavioral 
models of anxiety disorders, safety behavior prevents the acquisition of accurate threat-relevant 
information via a misattribution of safety in threatening situations (Salkovskis, 1991).  Due to 
this proposed misattribution, anxious individuals fail to disconfirm the likelihood and/or relative 
dangerousness of their feared outcome(s).  From this theory, it follows that safety behavior may 
undermine the efficacy of exposure therapy, as clients/patients who employ safety behavior 
during treatment may erroneously attribute the success of the exposure and/or the non-
occurrence of feared outcomes to the safety behavior.  Indeed, several studies have shown that 
safety behavior interferes with the efficacy of exposure, such that participants who used safety 
behavior during exposure demonstrated poorer outcomes in terms of fear reduction and cognitive 
change than participants who did not use safety behavior (Kim, 2005; McManus, Sacadura, & 
Clark, 2008; Salkovskis, Clark, Hackmann, Wells, & Gelder, 1999; Sloan & Telch, 2002; Taylor 
& Alden, 2010).  In fact, the mere availability of safety behavior has been shown to undermine 
the efficacy of exposure (Powers, Smits, & Telch, 2004), although an independent team of 
investigators failed to replicate this effect (Sy, Dixon, Lickel, Nelson, & Deacon, 2011).  Taken 
together, these findings suggest that safety behavior is detrimental to treatment outcome.  As 
such, many cognitive-behavioral treatment manuals and books advise against the use of safety 
behavior in treatment, or recommend that it be eliminated as soon as possible (e.g., Abramowitz, 
Deacon, & Whiteside, 2011; Foa, Yadin, & Lichner, 2012).   
In contrast to these results, a growing body of literature suggests that safety behavior may 
not necessarily undermine the efficacy of CBT.  These studies have generally shown that 
participants who employed safety behavior during exposure demonstrated comparable outcomes 
as compared participants who did not use safety behavior (Goetz & Lee, 2015; Hood, Antony, 
Koerner, & Monson, 2010; van den Hout, Engelhard, Toffolo, & van Uijen, 2011; Sy et al., 
2011; Rachman, Shafran, Radomsky, & Zysk, 2011; Milosevic & Radomsky, 2008, 2013a).  In 
fact, some research has found more favorable outcomes in exposure with safety behavior (ESB), 




feared stimuli, and/or lower distress ratings than participants receiving traditional exposure (e.g., 
Milosevic & Radomsky, 2008, 2013a).  The findings from these studies are in direct opposition 
to cognitive-behavioral theory (Salkovskis, 1991; Salkovkis et al., 1996), and instead support the 
notion that safety behavior is not necessarily deleterious to treatment, and may be beneficial in 
certain cases (Parrish, Radomsky, & Dugas, 2008; Rachman et al., 2008). 
According to Rachman et al. (2008), the potential benefits of using safety behavior in 
CBT may be explained by cognitive theory.  The authors posited that safety behavior may 
facilitate disconfirmatory experiences and increase perceptions of self-efficacy and control 
during treatment.  Self-efficacy is “the conviction that one can successfully execute the behavior 
required to produce [certain] outcomes” (Bandura, 1977, p. 193).  In other words, self-efficacy is 
an individual’s perceived sense of mastery, competence, and confidence in a given situation.  If 
self-efficacy beliefs are low, individuals will believe they cannot manage or cope with the 
situation, and thus will become distressed and/or engage in avoidance behavior.  According to 
self-efficacy theory (Bandura, 1977, 1988), activities which diminish anxiety and promote a 
sense of mastery and control in threatening situations will reduce fear.  As such, it could be that 
safety behavior may enhance therapeutic success by reducing anxiety and promoting a sense of 
confidence during exposure, which may in turn facilitate the acquisition of disconfirmatory 
information.  Indeed, Bandura’s early work demonstrated that providing anxious individuals with 
“response induction aids” (e.g., protective gloves) during exposure to a feared stimulus resulted 
in superior treatment outcome as compared to when such aids were withheld (Bandura, Jeffery, 
& Wright, 1974).  In light of these findings, Rachman et al. (2008) suggested that safety behavior 
may enhance the efficacy and acceptability of exposure-based treatments via increases in self-
efficacy beliefs.  If clients/patients are provided with safety behavior during the more 
challenging stages of treatment until they feel ready to eliminate it, perhaps they will feel more 
confident and in-control as treatment progresses.   
Consistent with Rachman et al. (2008), recent research has shown that CBT with safety 
behavior is rated as more acceptable than traditional CBT (Levy & Radomsky, 2014; Levy, 
Senn, & Radomsky, 2014; Milosevic & Radomsky, 2013b).  However, another study failed to 
find differences in acceptability between traditional exposure and ESB (Deacon, Sy, Lickel, & 
Nelson, 2010).  As such, more research is needed to clarify the acceptability-enhancing potential 




benefits to using safety behavior in CBT.  For example, Milosevic and Radomsky (2013a) 
reported that participants receiving ESB for spider fear demonstrated greater reductions in 
targeted threat beliefs about spiders than participants receiving traditional exposure.  Consistent 
with these results, Goetz and Lee (2015) recently found that exposure with “restorative” safety 
behavior (i.e., safety behavior that is employed in order to restore safety after confrontation with 
a perceived threat) resulted in greater and more rapid decreases in contamination fear as 
compared to exposure without safety behavior.  While preliminary, these findings support the 
potential advantages of safety behaviour in CBT, particularly with regard to treatment 
acceptability, cognitive change, and fear reduction.   
Taken together, current literature suggests that safety behavior may not always be 
detrimental to CBT, and may even be facilitative in some situations.  Unfortunately, to our 
knowledge there are currently no published recommendations for the judicious use of safety 
behavior in CBT, and many aspects of how safety behavior should be employed require 
clarification.  For instance, who should decide when to fade out the safety behavior during 
treatment, the client/patient or the therapist?  The current study aimed to address this question by 
comparing the efficacy and acceptability of participant- and experimenter-initiated fading of 
safety behavior during exposure to contamination.  In the participant-initiated (“PI”) condition, 
the participant elected when to eliminate the safety behavior, while in the experimenter-initiated 
conditions, the experimenter indicated when to drop the safety behavior.  There were two 
experimenter-initiated fading conditions: one in which the time/trial number of safety behavior 
fading was yoked to the PI condition (i.e., to control for time, the experimenter-initiated time or 
“ET” condition), and the other which was based on decreasing subjective fear ratings (i.e., to 
simulate a more traditional exposure session, the experimenter-initiated distress or “ED” 
condition).  Because the primary aim of this study was to determine who should decide to fade 
the safety behavior, we felt it was important to control for when the safety behavior was faded; as 
such, the ET condition is a design-driven control condition.  The ED condition was included in 
order to maximize ecological validity, as we acknowledge that while the ET condition is more 
methodologically rigorous, it may be less representative of standard clinical practice.  
Consistent with self-efficacy theory (Bandura, 1977, 1988), it was hypothesized that the 
PI condition would demonstrate superior treatment outcome and greater self-efficacy as 




is because in the PI condition, participants elected when to eliminate the safety aid, thus 
promoting their perceptions of self-efficacy and control in a threatening situation.  Based on 
Rachman et al. (2008), it was further hypothesized that the PI condition would be rated as more 
acceptable than both ET (Hypothesis 2a) and ED (Hypothesis 2b).  
2. Method 
2.1. Participants 
Participants were 100 undergraduate students from Concordia University with subclinical 
levels of contamination fear who were recruited via an online participant pool website and flyers 
posted around campus.  Level of contamination fear was assessed using the contamination 
subscale of the Vancouver Obsessional Compulsive Inventory (“VOCI-Contamination”; 
Radomsky et al., 2006; Thordarson et al., 2004), which was administered as a study eligibility 
screener via the online participant pool website.  Those who scored a 12 or higher on the VOCI-
Contamination were invited to participate in the study.  A score of 12 is one standard deviation 
higher than the mean of the undergraduate sample used to validate the VOCI (see Radomsky et 
al., 2006).  The majority of participants was female (n = 90, 90.0%), with an average age of 23.5 
(SD = 6.3) years.  Most participants identified their ethnic background as Caucasian (n = 52, 
52.0%), with the rest identifying as Arab/West Asian (n = 10, 10.0%), South Asian (n = 8, 
8.0%), Other (n = 8, 8.0%), Black (n = 6, 6.0%), Chinese (n = 6, 6.0%), Latin-American (n = 5, 
5.0%), Filipino (n = 3, 3.0%), and Korean (n = 2, 2.0%).  Participants received course credit or 
entry into a cash draw for their participation.   
2.2. Measures 
2.2.1. Behavioral approach test (BAT).  The BAT is a behavioral measure of fear.  In 
the current study, it consisted of participants approaching a contaminant (a “dirty” bedpan; see 
Materials) as close as they were able on a 24-point hierarchy, ranging from standing outside the 
testing room containing the bedpan to touching directly above the bedpan liquid with both hands 
and then touching their lips with both hands.  This BAT has been adapted from previous research 
on contamination fear (Cougle, Wolitzy-Taylor, Lee, & Telch, 2007; Levy & Radomsky, 2014; 
Najmi, Tobin, & Amir, 2012).  Participants completed the BAT with an independent evaluator 
who was blind to condition assignment, and the number of steps completed served as the 




2.2.2. Credibility/Expectancy Questionnaire (CEQ).  The CEQ (Devilly & Borkovec, 
2000) is a 6-item questionnaire that assesses perceived credibility and expectancy of a given 
treatment.  Items are rated on a 9-point Likert scale (1 = not at all useful/logical and 9 = very 
useful/logical) or on an 11-point percentage scale (0% - 100% improvement in symptoms).  For 
scoring ease, the CEQ was modified to utilize only the 9-point Likert scale (G. Devilly, personal 
communication, February 5, 2013).  The authors reported a 2-factor solution for the CEQ, the 
first being treatment credibility and the second treatment expectancy.  The CEQ has 
demonstrated adequate internal consistency and retest reliability (Devilly & Borkovec, 2000), 
and both subscales demonstrated good internal consistency in the current study (all αs > .88). 
2.2.3. Endorsement and Discomfort Scale (EDS).  The EDS (Tarrier, Liversidge, & 
Gregg, 2006) is a 10-item questionnaire that assesses perceptions of treatment acceptability.  
Participants are asked to rate their agreement with a number of statements about a given 
treatment on a 9-point Likert scale (1 = disagree strongly and 9 = agree strongly).  The authors 
reported a 2-factor structure for the EDS, the first factor being treatment endorsement and the 
second factor treatment discomfort.  In the current study, the EDS was administered following 
completion of the exposure session, and participants were asked to consider the acceptability of 
the session as if it were incorporated into a complete treatment protocol (i.e., several exposure 
sessions, instead of just one).  The EDS demonstrated excellent internal consistency in the 
current study (α = .94).  
2.2.4. Obsessive Beliefs Questionnaire-44 (OBQ-44).  The OBQ-44 (Obsessive 
Compulsive Cognitions Working Group, 2005) is a 44-item questionnaire that assesses OCD-
related beliefs (e.g., inflated responsibility, intolerance of uncertainty).  Participants are asked to 
rate their agreement with each obsessive belief on a 7-point Likert scale (1 = disagree very much 
and 7 = agree very much).  Higher scores on the OBQ-44 indicate greater endorsement of 
obsessive beliefs.  The authors reported excellent internal consistency for the OBQ-44 in a 
clinical sample of individuals with OCD, and the measure demonstrated excellent internal 
consistency in the current study at pre- and post-treatment (both αs = .96).   
2.2.5. Subjective Units of Distress Scale (SUDS).  The SUDS (Wolpe, 1958) is a 
widely-used measure of subjective fear.  Participants are asked to rate how fearful they feel on a 
scale from 0 (neutral) to 100 (the worst distress you can imagine).  In the current study, the 




contaminant, the Anticipatory SUDS rating, and upon reaching the last step in the BAT they 
could attain, the Peak SUDS rating), as well as after each exposure trial for the duration of the 
exposure session.  
2.2.6. Self-efficacy.  Participants rated their self-efficacy by answering the following 
question: “On a scale from 0 to 100, if 0 is not at all confident and 100 is completely confident, 
how confident are you that you could repeat the task you have just done?” Self-efficacy ratings 
were taken prior to each exposure trial for the duration of the exposure session.  However, only 
the rating following the removal of safety behavior (i.e., the first trial in which participants did 
not use safety behavior) was compared between groups.  This is because we expected that safety 
behavior would change as a function of safety behavior fading, particularly for individuals in the 
PI group who elected when to eliminate their safety aid. 
2.2.7. Vancouver Obsessional Compulsive Inventory (VOCI).  The VOCI (Radomsky 
et al., 2006; Thordarson et al., 2004) is a 55-item questionnaire that assesses a range of OCD 
symptoms, including contamination fear and compulsive washing.  Participants are asked to rate 
the degree to which the items are true of them on a 5-point Likert scale (0 = not at all and 4 = 
very much).  The VOCI has shown excellent internal consistency in both student and clinical 
samples (all αs > .93), as well as convergent and divergent validity (Radomsky et al., 2006; 
Thordarson et al., 2004).  For the purposes of the current study, only the VOCI-Contamination 
was administered, and it demonstrated good internal consistency at pre- (α = .87) and post-
treatment (α = .88). 
2.3. Materials 
 2.3.1. Contaminants.  Before the exposure session, participants were presented with six 
contaminants, including rubbing the bottom of their shoes; handling old and worn Canadian 
currency; rummaging through a partly-filled garbage basket; handling an old telephone; handling 
a sealed biohazard bag containing a test tube labelled “PATH 194”; and handling a sealed 
biohazard bag containing discarded laboratory materials (e.g., a urine cup).  These contaminants 
have been used in previous research on exposure-based treatment for contamination fear (van 
den Hout et al., 2011; Rachman et al., 2011).  Participants were asked to touch the six 
contaminants in random order and to rate their SUDS while touching each item.  The object that 




 2.3.2. Safety aids.  Participants were presented with a variety of safety aids, including 
hand sanitizer, latex-free gloves, hygienic wipes, face masks, and a protective apron, and were 
asked to choose one safety aid to use during the exposure session. 
2.3.3. “Dirty” bedpan.  A bedpan containing a mixture of water and yellow food 
coloring was used as the contaminant for the BATs.  A similar object has been used in previous 
research on contamination fear (Levy & Radomsky, 2014; Olatunji, Lohr, Sawchuck, & Tolin, 
2007).   
2.4. Treatment Conditions 
 2.4.1. Condition assignment.  Participants were assigned to complete the exposure 
session under one of three fading conditions: PI, ET, or ED.  To control for time, the trial number 
at which participants were asked to fade their safety behavior in the ET condition was yoked to 
those of participants in the PI condition.  For example, if a participant in the PI condition elected 
to eliminate the safety aid during the 14
th
 exposure trial, then a participant in the ET condition 
was asked to drop the safety aid during the 14
th
 exposure trial.  In order to ensure the success of 
the yoking procedure, participants could not be randomly assigned to condition.  This is because 
one participant had to be assigned to the ET condition following a participant that had completed 
the PI condition, as the participant in the PI condition determined the trial at which the 
participant in the ET condition would be asked to drop the safety aid.  As such, participants were 
assigned to condition consecutively in blocks of three in the following order: 1) PI, 2) ET, and 3) 
ED, for the duration of the study. 
2.4.2. Condition rationale.  Prior to the exposure session, participants were provided 
with a brief rationale for exposure therapy, and were then asked to choose a safety aid for the 
exposure session.  To avoid implying the absolute necessity of the safety aid, the selection of 
safety aids was presented as follows: “To assist you with facing your fear, you can choose one 
item from this selection that might be helpful to you during the exposure session.  However, as 
you advance through the session, we will phase out this safety aid and continue to confront the 
contaminant without it.  This is because in treatment, the eventual goal is to face your fears 
without any assistance”.  If this was the PI condition, the rationale continued as follows: “You 
have been assigned to the condition where you will decide when to eliminate the safety aid.  
There will be 20 total trials of exposure to this [chosen contaminant], and you will be asked to 




continued as, “You have been assigned to the condition where I will decide when to eliminate 
the safety aid.  There will be 20 total trials of exposure to this [chosen contaminant], and at some 
point in time I will ask you to drop the safety aid”.  If this was the ED condition, the exposure 
rationale continued as follows: “You have been assigned to the condition where I will decide 
when to eliminate the safety aid.  There will be 20 total trials of exposure to this [chosen 
contaminant], and at some point I will ask you to drop the safety aid as your distress level comes 
down”.  Participants in the ED condition were asked to drop the safety aid once their SUDS 
rating declined to 50% or less of their initial trial rating.   
 2.4.3. Exposure session.  For all participants, the session consisted of 20 exposure trials 
to the target contaminant.  Each trial consisted of touching the contaminant, then waiting for a 
30-second delay prior to the next trial.  This exposure protocol was modeled from previous work 
in the safety behavior literature (see van den Hout et al., 2011 and Rachman et al., 2011).  Self-
efficacy ratings were taken prior to each touch, whereas SUDS ratings were taken after each 
touch.  In the first several trials, participants were permitted to use the safety aid.  For the 
remainder of the trials, they did not use the safety aid (either the participant or the experimenter 
decided when to eliminate it, depending on the condition; see above).  
2.5. Procedure 
 Potential participants completed the VOCI-Contamination, and those who scored a 12 or 
higher were invited to participate in the study.  Following the informed consent process, 
participants completed a battery of self-report questionnaires including a demographics 
questionnaire and several measures of symptom severity (see Measures).  Participants then 
completed the pre-treatment BAT with an independent evaluator who was blind to condition.  
Following the pre-treatment BAT, participants were assigned to condition and presented with the 
six contaminants (see Materials).  Once the most distressing object was determined, participants 
were provided with the condition rationale, and asked to choose a safety aid for the session (see 
description above).  Following the treatment rationale and selection of materials, participants 
completed the CEQ.  
Participants then completed the exposure session (see description above).  Following the 
session, participants completed the EDS and were then given a short break during which they 
were told to relax and read magazines.  After the break, participants were asked to complete the 




with the independent evaluator who at this point was not blind to time, but remained blind to 




 Ten participants were excluded for the following reasons: one reported SUDS ratings of 0 
for all six contaminants; one refused to complete the exposure session; one participant assigned 
to the PI condition refused to drop the safety aid during the session; two participants 
misunderstood the experimenter’s instructions and completed the questionnaires in the wrong 
order; two participants in the ED condition were mistakenly asked to drop the safety aid at the 
wrong time (e.g., prior to reaching a SUDS rating of 50% or less of their initial trial rating); and 
three participants in the ED condition never reached a SUDS rating of 50% or less of their first 
trial rating, and thus were never asked to drop the safety aid.  These 10 participants were 
excluded from the analyses that follow, leaving a final sample of 90 participants. 
3.2. Manipulation Check 
 In accordance with the yoking procedure, participants in the ET condition were asked to 
drop the safety aid at a predetermined time point, based on when participants in the PI condition 
had elected to eliminate their safety aid.  An independent samples t test confirmed that the 
yoking procedure was successful, as there were no significant differences in the trial number at 
which participants in the PI (M = 8.03, SD = 4.18) and ET (M = 8.06, SD = 4.18) conditions 
eliminated the safety aid, t(60) = -.03, p = .976, d = -.007.  However, there were significant 
differences between the PI (M = 8.03, SD = 4.18) and ED (M = 5.46, SD = 4.17) conditions in 
terms of the trial at which the safety aid was dropped, t(57) = 2.36, p = .022, d = .62.  
3.3. Group Comparisons at Pre-Treatment 
 To assess baseline comparability of groups, a series of one-way analyses of variance 
(ANOVAs) were conducted on the demographic variables and on the following pre-treatment 
measures: VOCI-Contamination, OBQ, BAT, and SUDS ratings.  Groups did not differ with 
respect to age [F(2, 87) = .11, p = .893, ηp
2
 = .003], sex [X
2
(2) = .49, p = .783], or any pre-
treatment measure (all Fs < 1.92, all ps > .05, all ηp
2
s < .04).  However, there was a trend for 
baseline group differences on the BAT, F(2, 87) = 3.04, p = .053, ηp
2
 = .07.  See Table 2 for 
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Note.  PI = Participant-initiated condition.  ET = Experimenter-initiated time condition.  ED = 
Experimenter-initiated distress condition.  VOCI-C = Vancouver Obsessional Compulsive 
Inventory – Contamination Subscale.  OBQ = Obsessive Beliefs Questionnaire.  BAT = 
Behavioral approach test.  A. SUDS = Anticipatory Subjective Units of Distress Scale ratings.   
P. SUDS = Peak Subjective Units of Distress Scale ratings. 
3.4. Treatment Outcome (Hypothesis 1a and 1b) 
3.4.1. Comparisons between PI and ET (Hypothesis 1a).  To compare the efficacy of 
PI and ET, a series of 2 x 2 (condition x time) mixed ANOVAs were conducted on 
contamination fear severity scores, obsessive beliefs, and SUDS ratings at pre- and post-
treatment.  There were significant main effects of time on the OBQ, F(1, 60) = 8.56, p = .005, ηp
2
 
= .13, and SUDS [Anticipatory, F(1, 60) = 21.51, p < .001, ηp
2
 = .26; Peak, F(1, 60) = 27.98, p < 
.001, ηp
2
 = .32], indicating that obsessive beliefs and subjective fear decreased over time.  There 
was no main effect of time on VOCI-Contamination, F(1, 60) = .32, p = .574, ηp
2 
= .01, 
indicating that contamination fear severity remained relatively stable over time.  Due to baseline 




conducted on this measure, controlling for pre-treatment BAT.  There was no significant 





There were significant interactions between condition and time on the OBQ, F(1, 60) = 
4.74, p = .033, ηp
2
 = .07, and between condition and time on Peak SUDS ratings, F(1, 60) = 5.40, 
p = .024, ηp
2
 = .08, such that participants in the PI condition demonstrated greater reductions in 
obsessive beliefs and peak fear from pre- to post-exposure.  These interactions are displayed in 
Figures 1 and 2, respectively. 
 
Figure 1.  Mean scores on the Obsessive Beliefs Questionnaire-44.  N = 62.  OBQ = Obsessive 
Beliefs Questionnaire.  PI = Participant-initiated condition.  ET = Experimenter-initiated time 
condition.  Error bars represent standard errors. 
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 This analysis was repeated without the pre-exposure BAT as the covariate as a 2 x 2 (condition x time) mixed 
ANOVA.  This analysis revealed no main effect of condition and a significant interaction, F(1, 60) = 3.72, p = .030, 
ηp
2





























Figure 2. Mean peak SUDS ratings.  N = 62.  SUDS = Subjective Units of Distress Scale.  PI = 
Participant-initiated condition.  ET = Experimenter-initiated time condition.  Error bars represent 
standard errors. 
 
 To compare self-efficacy ratings between PI and ET, a one-way ANOVA was conducted 
on self-efficacy ratings that were obtained on the exposure trial immediately following safety 
behavior elimination (see Measures, above).  This analysis revealed a significant effect of 
condition, F(1, 60) = 11.02, p = .002, ηp
2 
= .16, such that the PI group (M = 90.65, SD = 14.58) 
reported greater self-efficacy than the ET group (M = 67.10, SD = 36.72) during this trial.  
3.4.3. Comparisons between PI and ED (Hypothesis 1b).  To compare the efficacy of 
PI and ED, a series of 2 x 2 (condition x time) mixed ANCOVAs were conducted on 
contamination fear severity scores, obsessive beliefs, and SUDS ratings at pre- and post-
treatment.  Due to significant differences in the trial at which participants in PI and ED 
eliminated their safety aid (see above), all analyses were conducted while covarying the trial at 
which the safety aid was dropped.  There were significant main effects of time on the OBQ, F(1, 
56) = 10.66, p = .002, ηp
2
 = .16, and SUDS [Anticipatory, F(1, 56) = 19.76, p < .001, ηp
2 
= .26; 
Peak, F(1, 56) = 21.35, p < .001, ηp
2 
= .28], indicating that obsessive beliefs and subjective fear 
decreased over time.  There was a trend for a main effect of time on VOCI-Contamination, F(1, 
56) = 3.40, p = .071, ηp
2





























marginal degree over time.  A one-way ANCOVA controlling for pre-treatment BAT revealed 




.  There 
were no significant interactions. 
To compare self-efficacy between PI and ET, a one-way ANCOVA was conducted on 
self-efficacy ratings during the trial immediately following safety behavior elimination (see 
Measures, above).  Again, the trial at which safety behavior was eliminated was entered as a 
covariate.  This analysis revealed a significant effect of condition, F(1, 56) = 5.19, p = .027, ηp
2 
= 
.09, such that PI (M = 90.65, SD = 14.58) had greater self-efficacy than ED (M = 77.07, SD = 
28.78) during this trial.  
3.5. Treatment Credibility and Acceptability (Hypothesis 2a and 2b) 
 3.5.1. Comparisons between PI and ET (Hypothesis 2a).  To compare PI and ET on 
treatment credibility and acceptability, a series of independent samples t tests were conducted on 
CEQ and EDS scores.  There was a trend for CEQ Expectancy, t(60) = 1.80, p = .078, d = .46, 
such that PI (M = 15.61, SD = 4.86) received marginally higher expectancy ratings than ET(M = 
13.19, SD = 5.72).  There were no condition differences in CEQ Credibility or EDS (both ts < 
.50, both ps > .05, both ds < .13). 
 3.5.2. Comparisons between PI and ED (Hypothesis 2b).  To compare PI and ED on 
treatment credibility and acceptability, a series of independent samples t tests were conducted on 
CEQ and EDS scores, which revealed no significant condition differences (all ts < 1.55, all ps > 
.05, all ds < .41). 
4. Discussion 
 The aim of this study was to compare participant- and experimenter-initiated fading of 
safety behavior during exposure to contamination.  To enhance both experimental design and 
ecological validity, there were two experimenter-initiated conditions, one which controlled for 
time and the other which was based on decreasing subjective distress ratings.  All conditions 
improved on measures of behavioral approach and obsessive beliefs.  Compared to the 
experimenter-initiated time (ET) condition, the participant-initiated (PI) condition demonstrated 
greater reductions in obsessive beliefs and peak fear, greater self-efficacy, and marginally higher 
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 This analysis was repeated without the pre-exposure BAT as the covariate as a 2 x 2 (condition x time) mixed 
ANCOVA, controlling for the trial at which safety behavior was dropped.  This analysis revealed a marginal main 
effect of condition, F(1, 56) = 3.72, p = .059, ηp
2
 = .06 and a significant interaction, F(1, 56) = 5.86, p = .019, ηp
2
 = 




treatment expectancy ratings.  PI and experimenter-initiated distress (ED) were generally 
comparable in terms of treatment outcome and acceptability, although participants in the PI 
condition endorsed higher self-efficacy ratings during exposure.  The findings suggest that 
exposure with the judicious use of safety behavior may be more effective and acceptable when 
participants/clients determine the progression of the exposure session.   
 It was hypothesized that the PI condition would demonstrate superior treatment outcome 
and greater self-efficacy as compared to both the ET and ED conditions.  This hypothesis was 
partially supported.  Compared to the ET condition, participants in the PI condition demonstrated 
greater pre- to post-exposure reductions in obsessive beliefs and subjective anxiety, as well as 
higher self-efficacy ratings immediately following safety behavior fading.  These results support 
the self-efficacy theory of anxiety (Bandura, 1977, 1988), which postulates that activities which 
promote a sense of confidence and control in threatening situations will reduce fear and 
avoidance behavior.  Indeed, PI was intended to enhance perceptions of self-efficacy and control, 
as the participants themselves decided when to drop the safety behavior in this condition.  These 
findings are also consistent with Rachman et al. (2008), who proposed that safety behavior may 
enhance the efficacy and acceptability of exposure via increases in self-efficacy and control.  
Recent research suggests that safety behavior may enhance perceived control over distressing 
emotions during exposure, which may lead to more favorable treatment outcomes (van den Hout 
et al., 2011).  Indeed, there has been growing empirical interest in the notion of distress 
tolerance, or the ability to accept rather than experientially avoid uncomfortable emotions, which 
is considered by some to be an important mechanism of change in exposure therapy (Craske et 
al., 2008).  As such, it could be that safety behavior increases tolerance to manage anxiety-
provoking situations, which in turn may enhance exposure efficacy.  Based on the current study’s 
results, ESB may be more effective when combined with specific activities that promote self-
efficacy and control, such as participant-initiated safety behavior fading.  However, it should be 
noted that PI did not differ from ET on other measures of contamination fear severity in this 
study (e.g., behavioral approach).  Nevertheless, greater reduction in obsessive beliefs in the PI 
condition may be a more important finding, as cognitive theory suggests that belief change is an 
important determinant of behavioral change and symptom reduction (e.g., Hofmann, 
Asmundson, & Beck, 2013).  Indeed, Rachman et al. (2008) proposed that safety behavior may 




during treatment.  Of course, the degree to which safety behavior promotes belief change beyond 
a single session of exposure is an empirical question that was not addressed in this study.  
Furthermore, although previous studies have found significant reductions in threat beliefs 
following a single session of exposure (e.g., Milosevic & Radomsky, 2013a), it is somewhat 
surprising that belief endorsement decreased following a brief, single-session intervention, and 
so it will be important to replicate our findings over a longer intervention and follow-up period.   
Contrary to hypotheses, the PI condition did not demonstrate superior treatment outcome 
as compared to the ED condition, although self-efficacy ratings were significantly higher in PI.  
This is a surprising finding, as PI was more effective than the other experimenter-initiated 
condition (ET) on several outcome measures.  Based on self-efficacy theory (Bandura, 1977, 
1988), it follows that ED would result in poorer outcomes as compared to PI, as participants in 
the ED group did not have control over safety behavior fading.  Indeed, several participants 
assigned to ED made comments to suggest that they felt anxious during the exposure session 
simply because they did not know when they would be asked to drop the safety behavior.  
Nevertheless, these results indicate that experimenter-initiated safety behavior fading (based on 
subjective distress) did not undermine the efficacy of ESB.  On the other hand, it could be that 
participants in the ED condition perceived some level of control over safety behavior fading 
during the exposure session, as they were told that they would be asked to drop the safety aid “as 
their distress level comes down”, which is based on the participants’ own emotional reactions.  
As such, similar to the PI condition, participants in ED may have benefitted from increased self-
efficacy and control during exposure, thus leading to favorable outcomes.  Indeed, although self-
efficacy ratings were higher in PI as compared to ED, the average self-efficacy rating in the ED 
condition was approximately 77 (on an 100-point scale), suggesting that participants in ED 
experienced a high level of self-efficacy during exposure.  However, it should be noted that the 
time at which participants were asked to drop the safety behaviour could not be methodologically 
controlled in the ED condition, which may have impacted these results.  As described previously, 
we felt it was important to include the ED condition in order to simulate a more traditional 
exposure session, which progresses based on decreasing SUDS ratings.  Nevertheless, it will be 
important to replicate and extend our results in the absence of a time confound.   
Finally, it was hypothesized that the PI condition would be rated as more acceptable than 




between-group differences in perceptions of treatment credibility and acceptability.  PI received 
marginally higher treatment expectancy ratings as compared to ET, indicating that participants in 
the PI condition may have expected greater improvement in their contamination fear symptoms 
than participants in ET.  Nevertheless, these differences were not statistically significant.  The 
findings contrast with Rachman et al. (2008), who proposed that safety behavior may enhance 
treatment acceptability via increases in self-efficacy beliefs during treatment.  As such, it follows 
that treatment activities which promote perceptions of self-efficacy and control (such as 
participant-initiated safety behavior fading) may be considered more acceptable.  It should be 
noted that acceptability ratings as assessed by the EDS were indeed numerically higher in the PI 
condition (M = 71.35, SD = 10.24) as compared to ET (M = 69.87, SD = 13.61) and ED (M = 
65.50, SD = 17.87), although these differences were negligible and not statistically significant.  
In our previous work, ESB for contamination fear received lower acceptability ratings as 
assessed by the EDS (M = 57.27, SD = 17.65; see Levy & Radomsky, 2014) than all three ESB 
conditions in the current study (see mean ratings above).  As such, it is possible that a restricted 
range in EDS scores may have affected our ability to detect between-groups differences, as all 
three fading conditions received high acceptability ratings in this study.  Previous research 
suggests that safety behavior may enhance perceptions of treatment acceptability and anticipated 
adherence as compared to traditional exposure (Levy & Radomsky, 2014; Levy et al., 2014; 
Milosevic & Radomsky, 2013b).  Therefore, it could be that the mere presence of safety 
behavior, regardless of who decides when to fade it, increases acceptability and credibility.  Of 
course, replication and extension of this work will be important, as a single session of ESB is 
inadequate to assess the acceptability of a full course of CBT with the judicious use of safety 
behavior.   
 Taken together, the results of the current study suggest that anxious individuals may fare 
better in treatment when they have more control over the progression of exposure.  This can be 
more explicit, verbal control, as in the case of the PI condition, or more indirect control, as in the 
ED group.  However, it should be noted that participants in the ET condition demonstrated 
improvement on several measures of symptom severity, indicating that participant- versus 
experimenter-initiated fading of safety behavior may only have a small impact on treatment 
outcome.  There may be several explanations for these findings.  First, contrary to cognitive-




al., 1996), recent research supports the efficacy of ESB for a range of anxiety and related 
problems, including contamination fear (Goetz & Lee, 2015; Hood et al., 2010; van den Hout et 
al., 2011; Milosevic & Radomsky, 2008, 2013a; Rachman et al., 2011; Sy et al., 2011).  As such, 
it could be that the manner in which safety behavior is faded during exposure has little impact on 
an otherwise effective treatment such as ESB.  Second, recent literature suggests that safety 
behavior may improve outcomes in exposure by enhancing cognitive change (van den Hout et 
al., 2011; Milosevic & Radomsky, 2013a).  In light of these findings, it is possible that the 
presence of the safety behavior, regardless of how it was faded, may have led to favorable 
outcomes in the current study.  Indeed, all conditions improved on measures of cognitive change 
in this study, suggesting that safety behavior was effective in promoting (or at least not 
hindering) threat disconfirmation.  Overall, the findings of the current study lend additional 
support to a growing literature on the effectiveness of ESB, at least in the short term.  What 
remains to be addressed is the impact of safety behavior over a longer period of treatment and 
follow-up, which was not assessed in this study and has generally been neglected in the safety 
behavior literature.   
The current study is not without limitations.  First, a subclinical sample limits the 
generalizeability of the findings to clinical samples of individuals with diagnosable anxiety 
problems.  As such, replication and extension of the findings in clinical samples will be 
important.  Second, self-efficacy was assessed using a single-item prompt with unknown 
psychometric properties.  Although measures of self-efficacy in contamination fear have recently 
become available (e.g., Levy & Radomsky, in press), we felt that assessing self-efficacy during 
exposure would more accurately capture changes in self-efficacy as a function of safety behavior 
fading than measures of general (i.e., non-specific) contamination-related self-efficacy.  
Nevertheless, future research should replicate and extend our results using validated measures of 
self-efficacy in anxiety.  Third, treatment acceptability ratings were generally high across 
conditions in the current study, which may have interfered with our ability to detect between-
groups differences in acceptability (due to a restricted range in EDS scores).  Fourth, the single-
session design of the current study is inadequate to assess treatment outcome and acceptability in 
a complete exposure therapy protocol varying in safety behavior fading.  Furthermore, the 
absence of a no-safety behavior control condition precludes our ability to assess the efficacy of 




over a longer course of intervention that more accurately represents the length of standard CBT 
protocols and includes an exposure-only control group.  Fifth, to ensure the success of the yoking 
procedure (see description above), we were unable to randomly assign participants to condition 
in the current study, which may have impacted our results.  Similarly, in order to minimize 
confounds we felt it was important to standardize the procedure of the ED condition (i.e., fading 
safety behavior at a SUDS level of 50% or less of the initial trial rating), which may not 
represent standard clinical practice.  Indeed, in clinical settings safety behavior fading is often 
determined collaboratively between the client/patient and therapist.  Finally, Rachman et al. 
(2008) initially defined the judicious use of safety behavior as the implementation and then 
fading of safety behavior over a longer intervention period (e.g., incorporating safety behavior 
into several exposure sessions, and then gradually fading it out).  Using a single-session design, 
we were unable to assess the efficacy and acceptability of the judicious use of safety behavior as 
it was initially defined.   
4.1. Conclusion 
In conclusion, there are a number of important questions that remain about the judicious 
use of safety behavior that were not addressed in the current study.  Nevertheless, to our 
knowledge no prior studies have attempted to operationalize and define the practice of safety 
behavior fading, and so the current study has the potential to contribute to the literature on the 
judicious use of safety behavior in research and clinical practice.  Based on our results, ESB may 
be more effective when participants/clients control safety behavior fading, either by their verbal 
indication or by their own emotional reactions.  It is our hope that this research will inspire future 
work on the judicious use of safety behavior in CBT, particularly regarding the development of 







This program of research was designed to address the practical aspects of incorporating 
safety behaviour into exposure-based treatments for anxiety and related disorders.  Recent theory 
(Parrish et al., 2008; Rachman et al., 2008) and experimental research (Levy & Radomsky, 2014; 
Levy et al., 2014; Milosevic & Radomsky, 2013a) suggest that the judicious use of safety 
behaviour may enhance the acceptability of exposure.  However, to this author’s knowledge, 
there are currently no published recommendations for the judicious use of safety behaviour in 
CBT, and practical questions remain about how to employ safety behaviour in treatment.  To 
address some of these questions, Study 1 compared the efficacy and acceptability of exposure 
with different types of safety aids, while Study 2 examined the effect of participant- versus 
experimenter-initiated fading of safety behaviour during exposure.  Given the mixed and 
inconclusive findings on the impact of using safety behaviour in treatment, this program of 
research also aimed to elucidate the conditions under which safety behaviour may be beneficial 
versus deleterious to treatment success.  Finally, most published studies of safety behaviour in 
exposure have recruited undergraduate student samples, and so I aimed to address this gap in the 
literature by recruiting a clinical sample of individuals with diagnosable OCD as well as a 
subclinical sample of individuals with elevated contamination fears. 
Summary of findings 
 Study 1.  To assess the efficacy and acceptability of exposure with different kinds of 
safety behaviour, clinical participants with OCD and contamination fear (N = 57) were randomly 
assigned to receive an exposure session with no safety aid (ERP), a routinely-used safety (RU), 
or a never-used safety aid (NU).  Results demonstrated that all groups improved on measures of 
contamination fear severity, behavioural approach to a feared stimulus, and subjective distress 
ratings.  However, some between-groups differences in outcome and acceptability were 
observed.  As compared to RU, the NU condition demonstrated significantly lower self-reported 
contamination fear severity at post-treatment, as well as significantly higher treatment 
acceptability and anticipated adherence ratings.  NU and ERP were generally comparable in both 
outcome and acceptability, although there were some differences in favour of NU.  Taken 
together, the findings support the efficacy and acceptability of exposure with safety behaviour.  




anxiety disorders (Salkovskis, 1991; Salkovskis et al., 1996), but support the notion that safety 
behaviour is not always deleterious to treatment outcome, and may even be beneficial under 
certain conditions (Parrish et al., 2008; Rachman et al., 2008).  
 Study 2.  In order to compare the efficacy and acceptability of participant- and 
experimenter-initiated fading of safety behaviour during exposure, participants with subclinical 
contamination fear (N = 100) were assigned to receive an exposure session under one of three 
fading conditions: 1) participant-initiated (PI); 2) experimenter-initiated time (ET), in which the 
timing of safety behaviour fading was yoked to that which was observed in the PI condition; or 
3) experimenter-initiated distress (ED), in which fading was based on decreasing subjective fear 
ratings.  Compared to ET, the PI condition demonstrated greater reductions in obsessive beliefs 
and peak fear, as well as marginally higher treatment expectancy ratings.  There were no 
differences in outcome or acceptability between the PI and ED conditions.  Consistent with self-
efficacy theory (Bandura, 1977, 1988), these findings suggest that participant-initiated fading of 
safety behaviour may be more effective and acceptable.  These results support recent 
experimental research on the potential benefits of using safety behaviour in CBT, particularly 
with regard to treatment acceptability (e.g., Milosevic & Radomsky, 2013a) and cognitive 
change (e.g., Milosevic & Radomsky, 2013b).  Consistent with Study 1, these findings are 
contrary to traditional cognitive-behavioural accounts of the detrimental effects of safety 
behaviour (Salkovskis, 1991; Salkovskis et al., 1996), and instead suggest that safety behaviour 
may actually facilitate belief change and symptom reduction, at least in a single-session 
intervention.   
Theoretical implications 
 As reviewed previously, there are several theories to explain the potential deleterious 
effects of safety behaviour on treatment outcome.  Traditional behavioural theory suggests that 
safety behaviour interferes with IFA during exposure, which is considered by some to be an 
important mechanism of change in exposure-based treatments (Foa & Kozak, 1986).  
Cognitively-based approaches suggest that safety behaviour may interfere with threat 
disconfirmation via attentional processes (Sloan & Telch, 2002) or misattributions of safety 
(Salkovskis, 1991; Salkovskis et al., 1996).  Finally, neurobehavioural theory posits that safety 
behaviour may prevent the development of inhibitory (non-threat) associations during exposure 




cognitively-based theories of safety behaviour, as IFA and inhibitory learning were not explicitly 
assessed in these studies.  In particular, Salkovskis (1991) proposed that safety behaviour 
maintains anxiety by preventing disconfirmatory experiences, as anxious individuals who use 
safety behaviour when faced with threat may misattribute the non-occurrence of feared outcomes 
to the presence of the safety behaviour.  Based on the findings of the current research, safety 
behaviour may not necessarily interfere with disconfirmation as originally proposed.  Across two 
independent samples, the current studies demonstrated that safety behaviour did not undermine 
the efficacy of exposure, as all participants (whether they were using safety behaviour or not) 
demonstrated significant reductions in contamination fear severity, behavioural avoidance, and 
subjective anxiety.  Even routinely-used safety aids, which may be more likely to interfere with 
disconfirmation due to their frequent (and unnecessary) use, did not impair symptom reduction 
and cognitive change in the current research.  Consistent with recent calls for a 
“reconceptualization” of safety behaviour in CBT (Rachman et al., 2008), these findings suggest 
that safety behaviour may not interfere with treatment outcome, at least in a single session of 
exposure.  What remains to be addressed is the degree to which safety behaviour impacts 
treatment efficacy over a longer course of intervention and follow-up, neither of which was 
assessed in these studies.  However, given that Salkovskis et al. (1996) theorized that safety 
behaviour may prevent disconfirmation if used in any feared situation (even just one), the 
findings of the current studies may still have implications for cognitive-behavioural theory on 
safety behaviour.   
 The current research may also shed light on the factors which determine whether safety 
behaviour is facilitative versus detrimental to treatment outcome.  Indeed, inhibitory learning 
theory (Craske et al., 2014) posits that the effect of safety behaviour on corrective learning is 
determined by the strength of the safety behaviour in reducing anxiety as well as the potency of 
the feared stimulus in evoking anxiety.  As such, inhibitory learning theory may support the 
notion that safety behaviour is not always counter-therapeutic, and may only have a detrimental 
impact if this combination of factors is met.  Indeed, based on the findings of the current studies, 
there may be certain situations in which safety behaviour is beneficial (or at least not harmful) to 
treatment success.  In particular, the current results suggest that incorporating novel safety aids 
into treatment and allowing participants/clients to determine the progression of the exposure 




facilitative) to treatment outcome.  Indeed, meeting these two conditions actually improved 
treatment efficacy on certain outcome variables in the current investigations.  As such, novel 
safety aids and participant-initiated safety behaviour fading may be two ways in which to 
enhance the efficacy of ESB, although replication and extension of this work over a longer 
period of intervention and follow-up is needed.  
 Finally, the current research may have implications for theory on the acceptability-
enhancing potential of safety behaviour in CBT.  Rachman et al. (2008) proposed that safety 
behaviour may enhance treatment acceptability, and thus reduce problematic dropout and refusal 
rates in exposure-based treatments.  The current research found some support for this theory.  In 
Study 1, exposure with never-used safety aids received marginally higher treatment acceptability 
and anticipated adherence ratings than exposure with routinely-used safety aids, as well as 
marginally higher ratings than traditional exposure (ERP).  Based on these findings, exposure 
with certain kinds of safety behaviour (in this case, those which are novel) may enhance the 
acceptability of exposure, whereas other kinds of safety behaviour (i.e., those which are 
frequently used) may not.  Study 2 found that exposure with participant-initiated safety 
behaviour fading received marginally higher treatment expectancy ratings than exposure with 
experimenter-initiated fading.  However, there were no condition differences in treatment 
acceptability.  Taken together, the findings indicate that safety behaviour does not always 
enhance acceptability, but may do so under certain conditions.  Indeed, previous studies have 
shown that safety behaviour enhances acceptability to a greater degree when cognitively-based 
rationales are used in treatment, as compared to when extinction-based rationales are provided 
(Levy et al., 2014; Milosevic & Radomsky, 2013a).  As such, it appears that the way in which 
safety behaviour is incorporated into treatment may affect its acceptability-enhancing potential.  
However, these results should be interpreted with caution, as mean comparisons were not 
statistically significant (possibly due to inadequate statistical power).  Furthermore, the degree to 
which safety behaviour reduces treatment dropout and refusal is an empirical question that was 
not addressed in the current research.  Nevertheless, these studies provide preliminary support 
for Rachman et al. (2008), and suggest that safety behaviour may enhance perceptions of 





 This program of research aimed to make a first attempt at addressing some of the 
practical considerations for implementing safety behaviour in CBT.  The need for this research 
arose when preliminary results suggested that safety behaviour may be helpful in treatment (e.g., 
by enhancing treatment acceptability), but specific guidelines for how to use safety behaviour in 
CBT were lacking.  Based on the findings from Study 1, novel safety behaviour may be the most 
appropriate choice for use in treatment.  Indeed, participants in the NU condition had lower 
contamination fear severity at post-treatment than participants in RU and ERP.  On the other 
hand, it should be noted that traditional exposure (ERP) and exposure with routinely-used safety 
aids were also effective in reducing contamination fear severity in the current research.  As such, 
it could be that in vivo exposure to feared stimuli is so effective that the presence (or absence) of 
safety behaviour has relatively little impact.  Nevertheless, it is noteworthy that routinely-used 
safety aids did not interfere with symptom change among clinically anxious individuals in the 
current research.  Given that the majority of previous research on safety behaviour has recruited 
undergraduate student samples (e.g., Hood et al., 2010; Milosevic & Radomsky, 2008; Sy et al., 
2011), this is an interesting and important finding.  Based on these results, it could be that safety 
behaviour is particularly effective in promoting symptom reduction among individuals with more 
severe fears.  Indeed, Rachman et al. (2008, 2011) suggested that safety behaviour may be 
especially helpful for severe cases of anxiety, including individuals who did not tolerate and/or 
failed to respond to ERP.  Alternatively, it could be that participants in the RU condition felt 
confident and in-control during the exposure because they were permitted to use their own, most 
important safety aid during the session.  Rachman et al. (2008) suggested that any safety 
behaviour, if used strategically in treatment, may promote self-efficacy and control and thus 
enhance exposure efficacy.  From a cognitive perspective, it is possible that participants in the 
RU group used the exposure session to test out their beliefs about the necessity of the safety 
behaviour and/or its role in reducing distress, and thus may have obtained useful and potentially 
corrective information during the session.  Of course, these interpretations and suggestions for 
clinical practice are preliminary, and must be evaluated in future studies, especially those 
involving treatment-seeking participants with diagnosable anxiety disorders receiving full 
packages of CBT assessed over a meaningful follow-up period.  
Study 2 aimed to address the practical aspects of safety behaviour fading, and compared 




behaviour during exposure.  The results indicated that participant-initiated fading and 
experimenter-initiated fading based on subjective distress ratings were particularly effective in 
reducing contamination fear severity and obsessive beliefs, although participants in the time-
based condition also demonstrated improvement on these measures.  Based on these findings, 
allowing anxious individuals to control the progression of exposure (either based on verbal 
indication or subjective distress) may enhance the efficacy of ESB.  In the clinic, these decisions 
are often made in a collaborative fashion, with both client and therapist contributing equally to 
the therapy discussion.  Based on the current findings, however, it may be beneficial for clients 
to take the lead on these decisions, rather than a purely collaborative and equitable approach.  
These results are consistent with self-efficacy theory on the importance of building self-
confidence and control during treatment in order to enhance therapeutic success (Bandura, 1977, 
1988).  Further, as originally proposed by Rogers (1957), a necessary condition for therapeutic 
change is the therapist’s genuine and empathic understanding of the client and his/her problem 
from the client’s perspective.  Perhaps the best way to achieve this understanding is by allowing 
clients to determine the progression of therapy, including individual exposure sessions.  In terms 
of clinical practice, the current results may translate to allowing anxious individuals to decide 
when to eliminate safety behaviour in a given exposure session and/or over the course of 
treatment, as exposure becomes more and more challenging.  Again, these suggestions for 
clinical practice are preliminary, and must be investigated in future studies.  Nevertheless, it 
appears that activities which promote a sense of mastery and control during treatment may 
facilitate fear reduction, and as such may be useful in CBT.  
Beyond some of the specific practical considerations for incorporating safety behaviour 
into exposure-based treatments, this program of research may also have implications for clinical 
practice more generally, particularly in regards to the judicious use of safety behaviour.  First, 
given that ESB was comparably effective to traditional exposure (ERP) in the current research, 
perhaps clinicians should have greater flexibility to use safety behaviour in treatment.  In a more 
traditional CBT approach, clinicians are taught to advise their clients to eliminate all safety 
behaviours as soon as possible during treatment, or else the therapy will be ineffective.  Given 
the findings of the current studies and other recent work (e.g., Hood et al., 2010; Milosevic & 
Radomsky, 2013b; Rachman et al., 2011; Sy et al., 2011), clinicians may consider adopting a 




have difficulty committing to exposure and/or engaging with it.  In these situations, clinicians 
may propose the strategic use of safety behaviour for early exposure sessions, in order to 
promote client engagement and perceptions of self-efficacy and control.  Second, the ability to 
(judiciously) use safety behaviour in CBT may foster greater client involvement in clinical 
decision-making.  For instance, if a client seems particularly reticent about or afraid of exposure, 
then the client can be given the choice to use safety behaviour in the session, as well as the 
control over when to eliminate the safety behaviour during the session.  Of course, as initially 
proposed by Bandura (1977, 1988), promoting self-confidence and control during treatment 
(including clinical decision-making) may correspond to better outcomes.  Third, a more flexible 
approach to safety behaviour in clinical practice may increase the number of available treatment 
procedures and techniques.  For example, clinicians could use safety behaviour in a given 
exposure session or across multiple sessions, or they could use safety behaviour in an entirely 
different way, such as to test specific predictions about the use, necessity, and/or helpfulness of 
the safety behaviour.  Future research is needed in order to validate these suggestions for clinical 
practice.  However, given the extant literature, it appears that at least some flexibility regarding 
the use of safety behaviour in CBT is warranted.  
Limitations and future directions 
 There are several limitations of the current research program that warrant attention.  First, 
the single-session design of these studies precludes the ability to assess the impact of safety 
behaviour over a longer course of intervention and follow-up, both in terms of treatment 
outcome and perceptions of acceptability.  Indeed, the majority of previous studies on safety 
behaviour have employed single-single designs (e.g., Hood et al., 2010; McManus et al., 2008; 
Milosevic & Radomsky, 2008, 2013b; Powers et al., 2004; Sy et al., 2011), which do not provide 
any information about the long-term implications of using safety behaviour in exposure-based 
treatments.  As such, future research should consider employing multi-session designs that better 
represent the length of standard CBT protocols (e.g., 12 sessions), as well as short- and long-
term follow-up assessments.  This research will be important for several reasons.  First, studies 
employing multi-session designs with a follow-up period may clarify mixed and inconclusive 
findings regarding the impact of safety behaviour in CBT.  Indeed, it is possible that safety 
behaviour does not undermine treatment efficacy in the short term, but may be highly 




important information about treatment acceptability and adherence.  Given that Rachman et al. 
(2008) proposed that safety behaviour may reduce dropout and refusal rates in exposure-based 
treatments, it is critical that the effect of safety behaviour on treatment retention rates be 
explicitly assessed.  Again, it could be that safety behaviour enhances the acceptability of a 
single-session intervention, but may have no beneficial impact over a longer course of treatment.  
Third, multi-session designs with follow-up assessments may elucidate the factors which 
determine whether safety behaviour is helpful versus harmful to treatment outcome.  Based on 
the findings of the current research and some theoretical work (Rachman et al., 2008), it could be 
that safety behaviour is helpful for individuals with severe anxiety problems and/or among those 
who have failed to respond to traditional ERP.  Of course, these are empirical questions that can 
only be adequately assessed in a full-length treatment protocol.   
 A second limitation of the current research is the absence of adequate rationales for safety 
behaviour elimination.  In clinical practice, it is recommended that therapists conduct detailed 
discussions with their clients/patients about the potential for safety behaviour to maintain anxiety 
symptoms and/or to undermine treatment success (e.g., Abramowitz et al., 2011).  Because the 
current studies were brief and experimental in nature, only a short description of safety 
behaviour could be provided to participants.  Without a comprehensive understanding of safety 
behaviour and its potential implications, participants may not have been able to adequately assess 
their perceptions of an intervention that incorporates safety behaviour.  On the other hand, given 
the mixed findings on the effect of safety behaviour in treatment, it is unclear how a more 
thorough and comprehensive description of safety behaviour should be structured.  Current 
cognitive-behavioural treatment manuals recommend that the concept of safety behaviour be 
introduced during psychoeducation, and described as problematic and likely to undermine 
treatment success (e.g., Abramowitz et al., 2011; Foa et al., 2012).  This information may now be 
insufficient as it does not take into account the extant literature.  Nevertheless, the brief 
descriptions of safety behaviour that were provided in the current studies are likely inadequate to 
assess the efficacy and acceptability of ESB.  As such, future research should consider providing 
a more thorough and comprehensive description of safety behaviour prior to initiating exposure.  





 Another important limitation concerns the judicious use of safety behaviour, which was 
initially defined as the strategic implementation of safety behaviour in the early and/or more 
challenging stages of treatment and then gradually faded out (Rachman et al., 2008).  Based on 
this definition, it appears that the authors intended that safety behaviour be used over a longer 
course of intervention than what was employed in the current studies.  Indeed, in order to 
incorporate safety behaviour into particularly difficult sessions and to gradually eliminate it, a 
longer intervention than a single session is needed.  As such, it is possible that the current 
research did not assess the efficacy and acceptability of the judicious use of safety behaviour as it 
was initially defined.  In light of this limitation, future researchers may wish to consider 
expanding upon the current studies in several ways.  First, the original definition of judicious use 
specifies incorporating safety behaviour in the early and more challenging stages of treatment.  
As such, future studies may consider assessing outcome while implementing safety behaviour in 
early treatment sessions and then gradually fading it out, as well as following incorporation of 
safety behaviour into particularly challenging sessions (e.g., sessions that involve exposure to 
stimuli at the top of the fear hierarchy).  Second, Rachman et al. (2008) described the potential 
benefits of using safety behaviour within a cognitive framework, in which safety behaviour was 
theorized to improve outcomes by facilitating disconfirmatory experiences.  As such, future 
studies may consider assessing the efficacy and acceptability of using safety behaviour in a 
cognitively-focused treatment.  For example, safety behaviour may be implemented in 
behavioural experiments that are designed to test specific predictions about the necessity of 
safety behaviour.  Furthermore, previous research has shown that descriptions of cognitively-
based CBT incorporating safety behaviour are rated as more acceptable than descriptions of 
extinction-based CBT with safety behaviour (Levy et al., 2014; Milosevic & Radomsky, 2013a), 
and so further evaluation of safety behaviour within a cognitively-focused treatment is 
warranted.   
 Finally, the current research examined the impact of safety behaviour in the context of 
exposure-based treatment for contamination fear, which limits the generalizeability of the results 
to other interventions and mental health problems.  Given that previous research has implicated 
safety behaviour in the maintenance of many psychological problems, including panic disorder 
with agoraphobia (e.g., Salkovskis et al., 1999), social anxiety disorder (SAD; e.g., McManus et 




2004), generalized anxiety disorder (GAD; e.g., Beesdo-Baum et al., 2012), health anxiety (e.g., 
Olatunji, Etzel, Tomarken, Ciesielski, & Deacon, 2011), insomnia (e.g., Hood, Carney, & Harris, 
2011), and schizophrenia (e.g., Chaix et al., 2014), it will be important to determine the effect of 
safety behaviour on treatment outcome and acceptability for other problems besides 
contamination fear.  Indeed, it is possible that safety behaviour has only a benign impact on 
exposure-based treatment for contamination fear, but is detrimental to outcome in the context of 
other psychological disorders.  Furthermore, recent research suggests that individuals with 
certain anxiety disorders (e.g., SAD) are more likely to employ safety behaviour in threatening 
situations than individuals with other anxiety disorders (e.g., GAD) and healthy controls (Rowa 
et al., 2014); in addition, much (although not all) of the research demonstrating the 
countertherapeutic nature of safety behaviour has been established with participants diagnosed 
with SAD.  As such, it will be interesting and important to assess the impact of safety behaviour 
in CBT for different anxiety disorders and other mental health problems.  These investigations 
will aid in the assessment of safety behaviour in clinical practice, and may also inform the 
development of practical guidelines for using (or eliminating) safety behaviour in treatment. 
 There are other important areas for study in the safety behaviour literature.  First, as 
described previously, there is no consensus about how to classify safety behaviour as adaptive or 
maladaptive coping strategies (Thwaites & Freeston, 2005).  In fact, to this author’s knowledge 
only one prior study has examined the impact of different types of safety behaviour on treatment 
outcome in exposure therapy for anxiety (Goetz & Lee, 2015).  In particular, the authors 
compared the efficacy of exposure with preventive (i.e., used to prevent contact with a feared 
stimulus) and restorative (i.e., used to restore safety following contact with a feared stimulus) 
safety aids, and reported that exposure with restorative safety aids was more effective in 
reducing contamination fear severity.  However, this study used an undergraduate student sample 
of healthy (non-clinical) individuals, which limits the generalizeability of the results to clinically 
anxious samples.  Given the mixed findings concerning the impact of safety behaviour in 
exposure, it is important to establish a classification system that may account for the discrepant 
results.  This classification system will have implications for the assessment of safety behaviour 
in clinical settings, and it will inform the development of established guidelines for the 
elimination (or possible incorporation) of safety behaviour in CBT.  As suggested by Thwaites 




such their use may not interfere with treatment efficacy.  By contrast, other safety behaviours 
may actually increase the likelihood of feared outcomes, and thus may be more likely to prevent 
disconfirmation and undermine treatment efficacy.  For example, previous research has shown 
that individuals with SAD who employ safety behaviour in social situations receive poorer 
performance ratings than individuals who refrain from using safety behaviour (e.g., Furukawa et 
al., 2009; McManus et al., 2008; Taylor & Alden, 2010).  Without a proper classification system 
to distinguish adaptive and maladaptive coping strategies, it will be difficult for clinicians to 
assess and intervene with regard to safety behaviour. 
 Another important area for future study concerns the impact of covert (subtle) safety 
behaviour on treatment outcome.  Examples of covert safety behaviour include engaging in 
mental self-reassurance and thinking of pleasant or calming images.  Previous research has 
generally neglected the effect of covert safety behaviour on treatment outcome, and as such it is 
unclear whether covert safety behaviour has a deleterious impact on treatment efficacy.  The 
exception is distraction (e.g., reading a book or watching television to avoid thinking about 
feared situations), which has been examined in several studies on exposure-based treatments for 
anxiety disorders (e.g., Johnstone & Page, 2004; Kamphuis & Telch, 2000; Penfold & Page, 
1999).  Similar to the overt safety behaviour literature, mixed findings on the impact of 
distraction in exposure preclude any substantive conclusions.  As such, it is unclear whether 
covert safety behaviour interferes with outcome, or may be beneficial in certain cases.  Current 
cognitive-behavioural theory (Salkovskis et al., 1996) suggests that any behaviour that is 
performed in order to prevent feared outcomes, including subtle avoidance behaviour, may 
interfere with disconfirmation.  Nevertheless, it will be important to explicitly assess the effect of 
covert safety behaviour in CBT.   
Conclusion 
In sum, there are a number of important questions that remain about safety behaviour and 
its impact on treatment efficacy and acceptability.  There is a need for assessing the effect of 
safety behaviour over a longer period of intervention and follow-up, both in terms of treatment 
outcome and dropout/refusal rates.  Furthermore, future research is hampered by a lack of 
consensus regarding the classification of safety behaviour as beneficial or detrimental to fear 
reduction.  Beyond these suggestions for future study, it will be interesting and important to 




judicious use of safety behaviour that remain.  For instance, how should safety behaviour be 
faded across treatment sessions, if it is used for more than one?  Should safety behaviour only be 
used in session with a therapist, or can it also be implemented in homework exercises?  What 
about safety behaviours that are not objects, such as trusted others or caregivers?  Objects may 
be easy enough to incorporate into exposure sessions, but specific people may present ethical and 
logistical challenges.  Second, it will be interesting to further investigate the categorization of 
safety behaviour as detrimental or benign to fear reduction based on the short-term effects of its 
use.  Given that certain safety behaviours have paradoxical short-term effects, such that they 
actually increase the likelihood of feared outcomes (e.g., socially anxious individuals who avoid 
eye contact during a social gathering may be perceived as “weird” or unfriendly), it is likely that 
these behaviours are detrimental to symptom change.  By contrast, safety behaviours which are 
employed simply for comfort purposes (e.g., carrying around a “lucky” penny on exam day) may 
not be deleterious to treatment outcome.  Finally, and of particular interest to this author, it will 
be important to examine safety behaviour use in special populations and underserved groups, 
such as military veterans and victims of sexual violence.  It is possible that these individuals may 
utilize safety behaviours that are objectively dangerous or hazardous (e.g., weapons, mace, 
pepper spray), which may pose a unique ethical dilemma in treatment.   
Although this research program did not address any of these gaps in the literature, the 
current studies made a first attempt at establishing practical guidelines for the judicious use of 
safety behaviour in CBT.  Based on the results, safety behaviour may not necessarily undermine 
the efficacy of exposure for contamination fear, at least in a brief intervention.  Furthermore, 
there may be specific situations in which safety behaviour may actually facilitate treatment 
outcome, such as when novel safety aids are incorporated into exposure and when 
participants/clients control the progression of the exposure session.  While preliminary, these 
results could aid in establishing formal guidelines for the judicious use of safety behaviour in 
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Behavioural Approach Test for Study 1 









Stand outside the testing room with the door closed 
2 Enter the testing room and stand next to the door 
3 Approach bedpan within 3 feet 
4 Touch top of bedpan with a sheet of tissue 
5 Touch inside rim of bedpan with a sheet of tissue 
6 Touch directly above bedpan with a sheet of tissue 
7 Touch top of bedpan with right index finger 
8 Touch inside rim of bedpan with right index finger 
9 Touch directly above bedpan liquid with right index 
finger 
10 Touch top of bedpan with right hand 
11 Touch inside rim of bedpan with right hand 
12 Touch directly above bedpan liquid with right hand 
13 Touch top of bedpan with both hands 
14 Touch inside rim of bedpan with both hands 
15 Touch directly above bedpan liquid with both hands 
16 Touch top of bedpan with both hands, then touch arms 
and chest 
17 Touch inside rim of bedpan with both hands, then touch 
arms and chest 
18 Touch directly above bedpan liquid with both hands, then 
touch arms and chest 







Behavioural Approach Test for Study 2 









Stand outside the testing room with the door closed 
2 Enter the testing room and stand next to the door 
3 Approach bedpan within 3 feet 
4 Touch top of bedpan with a sheet of tissue 
5 Touch inside rim of bedpan with a sheet of tissue 
6 Touch directly above bedpan with a sheet of tissue 
7 Touch top of bedpan with right index finger 
8 Touch inside rim of bedpan with right index finger 
9 Touch directly above bedpan liquid with right index 
finger 
10 Touch top of bedpan with right hand 
11 Touch inside rim of bedpan with right hand 
12 Touch directly above bedpan liquid with right hand 
13 Touch top of bedpan with both hands 
14 Touch inside rim of bedpan with both hands 
15 Touch directly above bedpan liquid with both hands 
16 Touch top of bedpan with both hands, then touch arms 
and chest 
17 Touch inside rim of bedpan with both hands, then touch 
arms and chest 
18 Touch directly above bedpan liquid with both hands, 
then touch arms and chest 
19 Touch top of bedpan with both hands, then touch both 
cheeks 





21 Touch directly above bedpan liquid with both hands, 
then touch both cheeks 
22 Touch top of bedpan with both hands, then touch lips 
with both hands 
23 Touch inside rim of bedpan with both hands, then touch 
lips with both hands 
24 Touch directly above bedpan liquid with both hands, 
then touch lips with both hands 






Informed Consent Forms for Study 1 
CONSENT FORM TO PARTICIPATE IN X MARKS THE SPOT II 
I understand that I have been asked to participate in a research project being conducted by 
Hannah Levy (ha_levy@live.concordia.ca; 514-848-2424 ext. 5965) under the supervision of Dr. 
Adam S. Radomsky (adam.radomsky@concordia.ca; 514-848-2424 ext. 2202) in the Psychology 
Department of Concordia University. 
 
A. PURPOSE 
I have been informed that the purpose of this study is to evaluate a new treatment approach for 
contamination fear. Contamination fear is intense fear of objects that are perceived as dirty, 
disgusting, or illness-causing. Individuals with contamination fear experience severe anxiety and 
distress when confronted with these objects.  
 
B. PROCEDURES 
I have been informed that this study will take approximately 3-4 hours to complete. If I agree to 
participate in this study, I will begin with an interview, in which the experimenter will ask me 
some questions about anxiety and my everyday experiences. This interview will be audio-
recorded for consistency purposes. The audio file will not contain my name or any identifying 
information. Then, I will be asked to complete a brief questionnaire package, which will take 
approximately 35 minutes. Following the questionnaire package, I will be asked to approach a 
contaminant, as close as I am able, and then provide my anxiety rating. After approaching this 
contaminant, I will be asked to interact with a series of contaminants and to provide my anxiety 
rating. Following these interactions, I will complete the same questionnaire battery and approach 
the same contaminant as close as I am able, then provide my anxiety rating. Finally, I will be 
fully debriefed about the purpose of the study as well as the hypotheses.  
 
C. RISKS AND BENEFITS 
I understand that I may become distressed or uncomfortable when asked to approach and/or 
interact with the contaminants, and when completing questionnaires about my fears and 
emotions. I understand that my questionnaire data will be collected via the Internet on a 
Concordia University-based server. These questionnaires ask no questions regarding my name 
and they will not be connected in any way with my contact details. I am aware that this study 
employs a standardized protocol for which anxious and depressive symptoms are assessed. I will 
be provided access to a treatment resource manual containing information about self-help books 
and local treatment services. For my participation, I will be offered $40 OR entry into a cash 
draw for prizes ranging from $50 to $300. I may also experience a decrease in the severity of my 
contamination fear as a result of my participation in the study.  
 
D. CONDITIONS OF PARTICIPATION 
I understand that I am free to withdraw my consent and discontinue my participation in this study 
at any time, without any negative consequences whatsoever. I understand that my participation in 
this study is CONFIDENTIAL. All information obtained will be kept strictly confidential and 
will be stored under lock and key for a period of seven years, after which it will be shredded. 




research team. I understand that to ensure my confidentiality all data will be coded by number 
only and will be kept separate from my name. I understand that data from this study may be 
published, but that no identifying information will be released. 
 
If you have any questions concerning the study, please feel free to ask the experimenter now. If 
other questions or concerns come up following the study, please contact Hannah Levy, 
Department of Psychology, at (514) 848-2424, ext. 5965 or by email at 
ha_levy@live.concordia.ca; or Adam Radomsky, Department of Psychology, at (514) 848-2424, 
ext. 2202 or by email at adam.radomsky@concordia.ca.  
 
I HAVE CAREFULLY STUDIED THE ABOVE AND UNDERSTAND THIS 
AGREEMENT. I FREELY CONSENT AND VOLUNTARILY AGREE TO 
PARTICIPATE IN THIS STUDY. 
 
NAME (please print) ______________________________________________       
  




WITNESS SIGNATURE ____________________________________________ 
 
If at any time you have questions about your rights as a research participant, please contact the 







CONSENT FORM TO PARTICIPATE IN X MARKS THE SPOT II 
 
As you have just been informed, the use of deceptive information was essential in this study in 
order to simulate a real treatment session for contamination fear. During these real treatment 
sessions, individuals are exposed to the contaminants that they fear. 
 
By signing below you indicate that you have been informed of this minor deception and allow us 
to include your results in our analyses. Given the nature of this deception, we ask that you refrain 









If you have any questions concerning the study, please feel free to ask the experimenter now. If 
other questions or concerns come up following the study, please contact Hannah Levy, 
Department of Psychology, at (514) 848-2424, ext. 5965 or by email at 
ha_levy@live.concordia.ca; or Adam Radomsky, Department of Psychology, at (514) 848-2424, 






Informed Consent Forms for Study 2 
CONSENT FORM TO PARTICIPATE IN X MARKS THE SPOT 
I understand that I have been asked to participate in a research project being conducted by 
Hannah Levy (ha_levy@live.concordia.ca; 514-848-2424 ext. 5965) under the supervision of Dr. 
Adam S. Radomsky (adam.radomsky@concordia.ca; 514-848-2424 ext. 2202) in the Psychology 
Department of Concordia University. 
 
A. PURPOSE 
I have been informed that the purpose of this study is to evaluate a new treatment approach for 
contamination fear. Contamination fear is intense fear of objects that are perceived as dirty, 
disgusting, or illness-causing. Individuals with contamination fear experience severe anxiety and 
distress when confronted with these objects.  
 
B. PROCEDURES 
I have been informed that this study will take approximately 2 hours to complete. If I agree to 
participate in this study, I will begin with a questionnaire package. Then, I will meet a trained 
research assistant who will ask me to approach a contaminant, as close as I am able, and then to 
provide an anxiety rating. After approaching this contaminant, I will be asked to interact with a 
series of contaminants and to provide my anxiety rating for each one. Following these 
interactions, I will complete a second questionnaire battery, then meet the trained research 
assistant for a second approach and provide my anxiety rating. Finally, I will be fully debriefed 
about the purpose of the study as well as the hypotheses.  
 
C. RISKS AND BENEFITS 
I understand that I may become distressed or uncomfortable when asked to approach and/or 
interact with the contaminants, and when completing questionnaires about my fears and 
emotions. I understand that my questionnaire data will be collected via the Internet on a 
Concordia University-based server. These questionnaires ask no questions regarding my name 
and they will not be connected in any way with my contact details. I am aware that this study 
employs a standardized protocol for which anxious and depressive symptoms are assessed. I will 
be provided access to a treatment resource manual containing information about self-help books 
and local treatment services. For my participation, I will receive the opportunity to submit my 
name in a draw for cash prizes ranging from $50 to $300, OR 2 course credits if I am part of the 
undergraduate participant pool at Concordia University. I may also experience a decrease in the 
severity of my contamination fear as a result of my participation in the study. 
 
D. CONDITIONS OF PARTICIPATION 
I understand that I am free to withdraw my consent and discontinue my participation in this study 
at any time, without any negative consequences whatsoever. I understand that my participation in 
this study is CONFIDENTIAL. All information obtained will be kept strictly confidential and 
will be stored under lock and key for a period of seven years after which it will be shredded. 
Access to this information will be made available only to restricted members of Dr. Radomsky’s 




only and will be kept separate from my name. I understand that data from this study may be 
published, but that no identifying information will be released. 
 
If you have any questions concerning the study, please feel free to ask the experimenter now. If 
other questions or concerns come up following the study, please contact Hannah Levy, 
Department of Psychology, at (514) 848-2424, ext. 5965 or by email at 
ha_levy@live.concordia.ca; or Adam Radomsky, Department of Psychology, at (514) 848-2424, 
ext. 2202 or by email at adam.radomsky@concordia.ca.  
 
I HAVE CAREFULLY STUDIED THE ABOVE AND UNDERSTAND THIS 
AGREEMENT. I FREELY CONSENT AND VOLUNTARILY AGREE TO 
PARTICIPATE IN THIS STUDY. 
 
NAME (please print) __________________________________       
  




WITNESS SIGNATURE _______________________________ 
 
If at any time you have questions about your rights as a research participant, please contact the 






CONSENT FORM TO PARTICIPATE IN X MARKS THE SPOT 
 
As you have just been informed, the use of deceptive information was essential in this study in 
order to simulate a real treatment session for contamination fear. During these real treatment 
sessions, individuals are exposed to the contaminants that they fear. 
 
By signing below you indicate that you have been informed of this minor deception and allow us 
to include your results in our analyses. Given the nature of this deception, we ask that you refrain 








If you have any questions concerning the study, please feel free to ask the experimenter now. If 
other questions or concerns come up following the study, please contact Hannah Levy, 
Department of Psychology, at (514) 848-2424, ext. 5965 or by email at 
ha_levy@live.concordia.ca; or Adam Radomsky, Department of Psychology, at (514) 848-2424, 






Debriefing Form for Study 1 
Debriefing 
Thank you for your time and cooperation. The purpose of this study is to evaluate the efficacy 
and acceptability of a new cognitive-behavioural treatment approach for contamination fear. 
Traditional cognitive-behavioural therapy (CBT) can be very difficult for people with severe 
contamination fear, because it often involves exposure to contaminants they are very afraid of. 
For this reason, many people refuse the treatment entirely, or drop out before the treatment has a 
chance to help them. In conducting this study, our intention is to modify this treatment to make it 
more acceptable for people with significant fears. We are comparing traditional CBT for 
contamination fear with CBT that includes safety gear, which are items that might make people 
feel more comfortable during exposure therapy. Some participants in this study are offered a new 
kind of safety gear they have never used, some are asked to use a safety gear they already use in 
their daily lives, and some are not offered any safety gear. We hypothesize that the treatment in 
which participants use a new kind of safety gear will be most effective compared to CBT with no 
safety gear and CBT with a routinely-used kind of safety gear. We also hypothesize that the 
treatments with safety gear will be more acceptable to participants. This is because we think that 
treatment with safety gear will feel less threatening and anxiety-provoking to participants.  
 
If you have any questions or comments about this study, please contact Hannah Levy 
(ha_levy@live.concordia.ca; 514-848-2424, ext. 5965) or Dr. Adam Radomsky 
(adam.radomsky@concordia.ca; 514-848-2424, ext. 2202).  If you are interested in the results of 
this study, you may contact Hannah Levy at the completion of the study.  Note that only global 
results, not individual results, will be released.   
 
In our research, we ask you many questions about feelings related to anxiety and sadness. If at 
any time you feel that you need help related to these feelings or other problems, please go to the 
treatment manual on our website for information on local resources (see below). Also, please 
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Debriefing Form for Study 2 
Debriefing 
Thank you for your time and cooperation. The purpose of this study is to evaluate the efficacy 
and acceptability of a new cognitive-behavioural treatment approach for contamination fear. 
Traditional cognitive-behavioural therapy (CBT) can be very difficult for people with severe 
contamination fear, because it often involves exposure to contaminants they are very afraid of. 
For this reason, many people refuse the treatment entirely, or drop out before the treatment has a 
chance to help them. In conducting this study, our intention is to modify this treatment to make it 
more acceptable for people. This is why you were offered a selection of protective items to use 
during the exposure session, because we thought these items might make the exposure easier for 
you. We are also investigating the optimal way to phase out the protective items. In particular, 
who should decide when to eliminate them, the participant or the experimenter? We are 
comparing three conditions: one where the participant decides to phase out the protective item; 
one where the experimenter decides based on the participant’s self-reported distress level; and 
one where the experimenter decides based on a predetermined time point. We hypothesize that 
the condition in which the participant decides will demonstrate greater treatment efficacy and 
acceptability than the two experimenter-decides conditions. This is because we think that 
participants will feel more confident and more in-control when they decide how the exposure 
session will progress. 
 
If you have any questions or comments about this study or to contact the laboratory for your 
compensation, please contact Hannah Levy (ha_levy@live.concordia.ca; 514-848-2424, ext. 
5965) or Dr. Adam Radomsky (adam.radomsky@concordia.ca).  If you are interested in the 
results of this study, you may contact Hannah Levy at the completion of the study.  Note that 
only global results, not individual results, will be released.   
 
In our research, we ask you many questions about feelings related to anxiety and sadness. If at 
any time you feel that you need help related to these feelings or other problems, please go to the 
treatment manual on our website for information on local resources (see below). Also, please 
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